Home
Search
BIO Digital

Speakers & Presenters

Meet the experts speaking on our world-class education program.

June 8-12, 2020
Search
Event Menu
Event Menu
Search General Info
Search Education
Search Partnering Companies

2020 BIO Digital Thought Leaders

 

Featured Speakers
Sharon Chan
Sharon Chan, MBA, MPH, D. Phil
HEAD JLABS @ SHANGHAI, JOHNSON & JOHNSON INNOVATION
Sharon Chan is the Head of JLABS @ Shanghai. In this role, Sharon is responsible for setting the strategic direction and overseeing all operational…
photo
Paul Stoffels, MD
VICE CHAIRMAN OF THE EXECUTIVE COMMITTEE AND CHIEF SCIENTIFIC OFFICER, JOHNSON & JOHNSON
Paul Stoffels is a visionary leader who inspires and drives transformational innovation to bring years of life and quality of life to millions of…
photo
Anthony Fauci, MD
DIRECTOR, NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES, NATIONAL INSTITUTES OF HEALTH
ANTHONY S. FAUCI, MD is director of the National Institute of Allergy and Infectious Diseases (NIAID) at the U.S. National Institutes of Health,…
Sharon Chan
photo
photo
All Speakers
By Count | Alphabetical
  • Show All
By Count | Alphabetical
  • Show All
By Count | Alphabetical
  • Show All
Company Type
  • Show All
Main Therapeutic Focus
  • Show All
Development Phase of Primary Product
  • Show All
Search Speakers
All Speakers
Filter by letter
A
B
C
D
E
F
G
H
I
J
K
L
M
N
O
P
Q
R
S
T
U
V
W
X
Y
Z
photo
Stephen M. Hahn, MD
COMMISSIONER OF FOOD AND DRUGS, U.S. FOOD AND DRUG ADMINISTRATION
Fireside Chat with FDA Commissioner Dr. Stephen M. Hahn
photo
Federico Mingozzi, PhD
CHIEF SCIENTIFIC OFFICER, SPARK THERAPEUTICS
The Next Generation of Medicine: Cell Therapies, Gene Therapies and Beyond
United States
photo
James Sabry, MD, PhD
GLOBAL HEAD, PHARMA PARTNERING, ROCHE
The Next Generation of Medicine: Cell Therapies, Gene Therapies and Beyond
photo
Raolat Abdulai, MD, MS
CLINICAL DIRECTOR OF RESEARCH, SANOFI
Digital Health in Respiratory Care – The Next Frontier
Cambridge, Massachusetts, United States
photo
Amy Abernethy, MD, PhD
PRINCIPAL DEPUTY COMMISSIONER AND ACTING CHIEF INFORMATION OFFICER, FOOD AND DRUG ADMINISTRATION
The Convergence of Health and Tech: Personalizing Medicine Beyond the Imaginable
Washington DC, United States
photo
Charlotte Abitbol
BUSINESS DEVELOPMENT DIRECTOR HEALTHCARE, BUSINESS FRANCE
France, the most attractive country in Europe for FDI
San Francisco, California, United States
photo
Wade Ackerman, JD
PARTNER, COVINGTON & BURLING
Patient-Centric 2.0: Are We Ready for Decentralized Trials?
Los Angeles, California, United States
photo
Julian Adams, PhD
CEO, GAMIDA CELL
Transplant 2.0: Driving Forward Innovation for Patients with Blood Cancer
Boston, Massachusetts, United States
photo
Amos Adler
CEO, A4I
A4i
Toronto, Ontario, Canada
photo
Sudhir Agarwal, FRSC, D. Phil
VISITING PROFESSOR IN THE DEPARTMENT OF MEDICINE, UNIVERSITY OF MASSACHUSETTS MEDICAL SCHOOL; FOUNDER AND PRESIDENT, ARNAY SCIENCES, ARNAY SCIENCES
'N of Few' - Clinical Trial Design for Small Cohorts
United States
photo
Priyanka Agarwal, MBA, MD
DIRECTOR, DIGITAL HEALTH, MYOKARDIA, INC.
Addressing the Unmet Need in Cardiovascular Disease Development
photo
Amirah Al Idrus
EDITOR, FIERCEBIOTECH
Diversity and Inclusion in Biotech’s Explosion: ERG and Non-Profit Perspectives
United States
photo
Meg Alexander
HEAD, REPUTATION & RISK MANAGEMENT PRACTICE, SYNEOS HEALTH COMMUNICATIONS
In an Era of Partisan Stalemate, What Drug Pricing Policies Can the Executive Branch Enact Without Congressional Authority?
New York, New York, United States
photo
Paul Aliu, MBA, MRPharmS, PharmD
GLOBAL HEAD MEDICAL GOVERNANCE, CHIEF MEDICAL OFFICE, NOVARTIS PHARMA AG
Bioethics Through the Lens of a Pandemic
Basel, Switzerland
photo
Rob Allen
SENIOR VICE PRESIDENT AND CHIEF OPERATING OFFICER, INTERMOUNTAIN HEALTHCARE SYSTEMS
Reinventing Partnerships to Deliver Value for Patients & Society
Salt Lake City, Utah, United States
photo
Michael Altorfer
CEO, SWISS BIOTECH ASSOCIATION
Biotech Hub Switzerland - stronger and more diverse
photo
Brad Amendt
OWNER AND CSO, NATUREMIRI, LLC
NaturemiRI, LLC
Iowa City, Iowa, United States
photo
Margaret Anderson
MANAGING DIRECTOR, DELOITTE CONSULTING LLP
Fireside Chat with Dave Ricks, Chairman and Chief Executive Officer, Eli Lilly and Company
Washington, United States
photo
Ayla Annac
CEO/PRESIDENT, INVIVOSCIENCES, INC.
InvivoSciences, inc.
Madison, Wisconsin, United States
photo
Ami Appelbaum
CHAIRMAN OF THE BOARD, ISRAEL INNOVATION AUTHORITY & CHIEF SCIENTIST, MINISTRY OF ECONOMY AND INDUSTRY
International Plenary Session: How are Global Leaders Collaborating to Combat the Pandemic?
TEL AVIV-YAFO, Israel
photo
Fumito Aranami
MANAGER, OITA IAM
Oita IAM
Oita , Japan
photo
Ksenija Pavletic Aranicki, MBA, MSc
CEO, GEDEON RICHTER PREGLEM
Redefining BioPharma in a Female-Forward World
Geneva, Switzerland
photo
Arsalan Arif
CEO AND FOUNDER, ENDPOINTS NEWS
Gene Therapy: The Long Horizon and Broad Challenges
Lawrence, Kansas, United States
photo
Cameron Arterton
VICE PRESIDENT, TAX POLICY, EMERGING COMPANIES, BIOTECHNOLOGY INNOVATION ORGANIZATION (BIO)
Federal Economic Recovery Efforts for Small Biotechnology Companies
Examining Foreign-Source Threats to Biotechnology: A Conversation with the National Security Community
Washington, United States
photo
Phyllis Arthur, MBA
VICE PRESIDENT, INFECTIOUS DISEASES AND DIAGNOSTICS POLICY, BIOTECHNOLOGY INNOVATION ORGANIZATION
Leveraging Innovative Technology to Treat COVID-19 Patients
A Way Forward: Winning the War on COVID through Vaccines
The Need for Speed: Developing COVID-19 Vaccines and Therapeutics
Washington, District Of Columbia, United States
photo
Hartley Atkinson
CEO AND FOUNDER, AFT PHARMACEUTICALS
AFT Pharmaceuticals
Auckland, New Zealand
photo
Joel Austin, Please Select, PhD
CSO, CHIROMICS LLC
Chiromics LLC
West Windsor, New Jersey, United States
photo
Mario Avarello, BSc, MSc, PhD
SCIENTIFIC ACCOUNT MANAGER BUSINESS DEVELOPMENT, GENOMIC VISION
Genomic Vision
Bagneux, France
photo
Wooyeol Baek
CEO, PLCOSKIN INC.
PLCOSKIN Inc.
Seoul, Korea, Republic of
photo
Christopher Bahl, MS, PhD
HEAD OF PROTEIN DESIGN, INSTITUTE FOR PROTEIN INNOVATION
Institute for Protein Innovation
Boston, Massachusetts, United States
photo
Rebecca Baker, PhD
DIRECTOR, HELPING TO END ADDICTION LONG-TERM (HEAL) INITIATIVE, NATIONAL INSTITUTES OF HEALTH
Disruptive Thinking: What's Next for Pain
United States
photo
David Baker
CEO, VALLON PHARMACEUTICALS
Vallon Pharmaceuticals
Philadelphia, Pennsylvania, United States
photo
Cheryl Baker, PhD
SCIENTIFIC FOUNDER AND CHIEF SCIENTIFIC RESEARCH OFFICER, BIOCURITY PHARMACEUTICALS INC.
BioCurity Pharmaceuticals Inc.
Jupiter, Florida, United States
photo
Sasha Bakhru, PhD
PRESIDENT & CHIEF EXECUTIVE OFFICER, PEROSPHERE TECHNOLOGIES
Addressing the Unmet Need in Cardiovascular Disease Development
United States
photo
Stéphane Bancel
CHIEF EXECUTIVE OFFICER, MODERNA THERAPEUTICS, INC
A Way Forward: Winning the War on COVID through Vaccines
Cambridge, Massachusetts, United States
photo
Jianxin Bao
CEO, GATEWAY BIOTECHNOLOGY, INC.
Gateway Biotechnology Inc.
Kent, Ohio, United States
photo
Erica Barnes
EXECUTIVE DIRECTOR, MINNESOTA RARE DISEASE ADVISORY COUNCIL
Gene Therapy: The Long Horizon and Broad Challenges
Saint Paul, Minnesota, United States
photo
Jenny Barnett
CEO, MONUMENT TX
Digital Biomarkers: A New Dawn in CNS R&D
Cambridge, United Kingdom
photo
Dror Bashan
CEO, PROTALIX BIOTHERAPEUTICS
Protalix BioTherapeutics
Carmiel, Israel
photo
Ken Batchelor, PhD
CEO, NOVATARG THERAPEUTICS
NovaTarg Therapeutics
Research Triangle Park, North Carolina, United States
photo
Alison Bateman-House, MPH, PhD, MA
ASSISTANT PROFESSOR, DIVISION OF MEDICAL ETHICS, NYU GROSSMAN SCHOOL OF MEDICINE
Bioethics Through the Lens of a Pandemic
New York, New York, United States
photo
Steve Bates
CHIEF EXECUTIVE OFFICER, UK BIOINDUSTRY ASSOCIATION (BIA)
International Plenary Session: How are Global Leaders Collaborating to Combat the Pandemic?
London, United Kingdom
photo
Jake Bauer
CHIEF BUSINESS OFFICER, MYOKARDIA
Precision Medicine Outside Oncology: One Size Does Not Fit All
San Francisco, California, United States
photo
Bruce Bauer, PhD
CEO, TAE LIFE SCIENCES
TAE Life Sciences
Foothill Ranch, California, United States
photo
Shannon Baumann
SENIOR DIRECTOR, ACCESS VALUE AND EVIDENCE STRATEGY, BLUEBIRD BIO
Precision financing for Durable/curative Therapies
photo
Susan Baxter, PhD
EXECUTIVE DIRECTOR, CALIFORNIA STATE UNIVERSITY PROGRAM FOR EDUCATION AND RESEARCH IN BIOTECHNOLOGY
Diversity and Inclusion in the Bio-innovation Ecosystem
San Diego, California, United States
photo
Mandy Bazile
DIRECTOR, GOVERNMENT AFFAIRS, PUBLIC POLICY & REIMBURSEMENT, GENENTECH
Access to Personalized Medicine Drives Utilization of Genomic Tests and Targeted Therapies
photo
Yvan Beaudoin
CEO, THORASYS
Thorasys
Montreal, Quebec, Canada
photo
Dirk Beelen
DIRECTOR , HEALTH AND MEDICAL INDUSTRIES SOUTH AUSTRALIA
Health and Medical Industries South Australia
Adelaide, Australia
photo
Sue Behrens, PhD
RATHMANN PROFESSOR IN BIOPROCESSING AND DIRECTOR OF THE AMGEN BIOPROCESSING CENTER, KECK GRADUATE INSTITUTE
Discover/Develop: But How Will you Manufacture Your Therapeutic?
Claremont, California, United States
photo
Piraye Beim
CEO, CELMATIX
Celmatix
New York, New York, United States
photo
Ksenia Belkina
CEO, CARDIOMO CARE, INC.
Cardiomo Care, Inc.
New York, New York, United States
photo
Marc L. Belsky
CHIEF FINANCIAL OFFICER AND SECRETARY, KEZAR LIFE SCIENCES
Federal Economic Recovery Efforts for Small Biotechnology Companies
South San Francisco, California, United States
photo
Rahima Benhabbour
FOUNDER & DIRECTOR, ANELLEO, INC.
Anelleo, Inc.
Chapel Hill, North Carolina, United States
photo
Richard Berenson
CHIEF EXECUTIVE OFFICER, THERMALIN INC.
Thermalin Inc.
Waban, Massachusetts, United States
photo
Fabian Berkemeier
DIRECTOR, VALUE AND ACCESS STRATEGY, IGES INSTITUT GMBH
How will healthcare systems adapt to the Post-COVID-19 World?
Berlin, Germany
photo
Seth Berkley
CEO, GAVI, THE VACCINE ALLIANCE
A Way Forward: Winning the War on COVID through Vaccines
New York, New York, United States
photo
Jeff Berkowitz, JD
CEO AND DIRECTOR, REAL ENDPOINTS
Rare Disease Therapies are No Longer Rare: Can the US Healthcare Reimbursement System Handle Chronic Treatments for Orphan Diseases
New Jersey, United States
photo
Sylvain Berlemont
CEO, KEEN EYE
KEEN EYE
Paris, France
photo
Arnaud Bernaert
HEAD OF HEALTH AND HEALTHCARE, MEMBER OF THE EXECUTIVE COMMITTEE, WORLD ECONOMIC FORUM
Reinventing Partnerships to Deliver Value for Patients & Society
cologny, Switzerland
photo
Brian Berridge, PhD
ASSOCIATE DIRECTOR, NATIONAL TOXICOLOGY PROGRAM; SCIENTIFIC DIRECTOR, DIVISION OF NTP, NIH
Organs-on-a-Chip and AI: Realizing Potential Efficiencies in Drug Discovery and Development
United States
photo
Gordon Bethwaite
ACTING CEO, NOVAI
Novai
San Diego, California, United States
photo
Ami Bhatt
ASSISTANT PROFESSOR, MEDICINE-HEMATOLOGY AND GENETICS, STANFORD UNIVERSITY
Next Generation Advances in Human Microbiome Research
Stanford, California, United States
photo
Indu Bhushan
CEO AYUSHMAN BHARAT & NATIONAL HEALTH AUTHORITY, GOVERNMENT OF INDIA
The Lure of Universal Healthcare ! What India is doing in Healthcare
New Delhi, India
photo
Barbara Bierer, MD
FACULTY DIRECTOR, MULTI-REGIONAL CLINICAL TRIALS CENTER OF BRIGHAM AND WOMEN'S HOSPITAL AND HARVARD
Including the Patient Voice to Advance Diversity and Support Clear Communications
Cambridge, Massachusetts, United States
photo
Igor Bilinsky
CHIEF BUSINESS OFFICER, ONCTERNAL THERAPEUTICS
Oncternal Therapeutics
San Diego, California, United States
photo
Louise Binder
HEALTH POLICY CONSULTANT, SAVE YOUR SKIN FOUNDATION
Closing the Gap Between Regulatory Approval and Public Pricing/Listing of Innovative BioPharmaceuticals
photo
Paul Biondi
EXECUTIVE PARTNER, FLAGSHIP PIONEERING
Getting a seat at the table: how can new small companies enter the oncology space?
Princeton, New Jersey, United States
photo
Lars Birgerson, MD, PhD
PRESIDENT & CEO, ADLAI NORTYE USA INC.
Adlai Nortye USA Inc
North Brunswick, New Jersey, United States
photo
Teresa Bitetti
PRESIDENT, GLOBAL ONCOLOGY, TAKEDA
What Was Hot at ASCO 2020? Highlights from the World’s Biggest Oncology Meeting
photo
Fritz Bittenbender
SENIOR VICE PRESIDENT, GOVERNMENT AFFAIRS, GENENTECH, A MEMBER OF THE ROCHE GROUP
In an Era of Partisan Stalemate, What Drug Pricing Policies Can the Executive Branch Enact Without Congressional Authority?
Washington, United States
photo
Clare Blain
CEO, LIFE SCIENCES QUEENSLAND LIMITED
Queensland, Australia - Global Innovation Hub
Brisbane, Australia
photo
Leah Bloom, PhD
SENIOR VICE PRESIDENT, EXTERNAL INNOVATION AND STRATEGIC ALLIANCES, AVEXIS, A NOVARTIS COMPANY
AveXis, Inc., a Novartis Company
Bannockburn, Illinois, United States
photo
Vincent Blouin, BSc, MBA
CHIEF MARKETING OFFICER, RASPBERRY SCIENTIFIC INC.
Raspberry Scientific Inc.
Magog, Quebec, Canada
photo
Ken Blount, PhD
CHIEF SCIENTIFIC OFFICER, REBIOTIX
Keys to the Cure: Will the Microbiome Live Up to the Hype?
United States
photo
Jeffrey Blue
DIRECTOR OF VACCINE DRUG PRODUCT DEVELOPMENT AND NEW TECHNOLOGIES, MERCK & CO.
Beyond the Needle: Novel Approaches to Vaccine Delivery
photo
Jeffrey Bockman, PhD
EVP, ONCOLOGY PRACTICE HEAD, CELLO HEALTH BIOCONSULTING (PREVIOUSLY DEFINED HEALTH)
Future of IO Checkpoint Combinations
United States
photo
Sierra Bodor, BS
PUBLIC HEALTH PROGRAM MANAGER, HEPATITIS B FOUNDATION
Developing a New Rare Disease Diagnostic: From Fueling Clinical Trials to Building a Market
Doylestown, Pennsylvania, United States
photo
Natasha Bonhomme
CHIEF STRATEGY OFFICER, GENETIC ALLIANCE
Next Generation Orphan Drug Incentives
Washington, United States
photo
Aarash Bordbar, PhD
CO-FOUNDER & CTO, SINOPIA BIOSCIENCES, INC.
Sinopia Biosciences, Inc.
San Diego, California, United States
photo
Christophe Bourdon
VICE PRESIDENT AND GENERAL MANGER, ONCOLOGY (US OPERATIONS), AMGEN INC.
International Plenary Session: How are Global Leaders Collaborating to Combat the Pandemic?
Vienna, Austria
photo
Terry Bowlin
PRESIDENT & CEO, MICROBIOTIX, INC.
Microbiotix, Inc.
Worcester, Massachusetts, United States
photo
Matt Bradley, PhD
CHAIRMAN, PRESIDENT, FOUNDER, SAJE PHARMA, LLC
SAJE Pharma, LLC
Kalispell, Montana, United States
photo
Kerrie Brady, Bpharm, MBA, MSc
CO-FOUNDER AND FORMER CBO CENTREXION
Demystifying buzzwords – How AI and machine learning are being used NOW in the life sciences
United States
photo
Kimberly Brandt
PRINCIPAL DEPUTY ADMINISTRATOR FOR POLICY & OPERATIONS, CENTERS FOR MEDICAID & MEDICARE SERVICES
Disruptive Thinking: What's Next for Pain
Baltimore, Maryland, United States
photo
Joel Braunstein, MBA, MD
CEO, C2N DIAGNOSTICS, LLC
Brave Innovations: Public and Private Solutions to Advance Alzheimer’s Therapeutics and Diagnostic in a Risk-Averse Climate
St. Louis, Missouri, United States
photo
Graham Brearley
GENERAL MANAGER, MADISON, CATALENT BIOLOGICS
How COVID-19 Is Reshaping Vaccine Development: Innovations in Vaccine Technology and Manufacturing Partnerships
photo
Isaac Bright
CEO, RUBRYC THERAPEUTICS, INC.
RubrYc Therapeutics, Inc.
San Carlos, California, United States
photo
Alex Brill
RESIDENT FELLOW, AMERICAN ENTERPRISE INSTITUTE
How can the U.S. cultivate a strong and competitive biosimilars market?
Washington, District Of Columbia, United States
photo
Remy Brim, PhD
VICE PRESIDENT REGULATORY POLICY AND STRATEGY, BGR GOVERNMENT AFFAIRS
In an Era of Partisan Stalemate, What Drug Pricing Policies Can the Executive Branch Enact Without Congressional Authority?
Washington, District Of Columbia, United States
photo
Nicholas Brooke
EXECUTIVE DIRECTOR, PATIENT FOCUSED MEDICINES DEVELOPMENT
Global Patient Advocacy in the COVID Era: What Is the Future of Patient Advocacy around the World?
Brussels,
photo
Nick Brown
NORTH AMERICAN BUSINESS DEVELOPMENT MANAGER, RETROGENIX LIMITED
Retrogenix Limited
Chinley, High Peak, United Kingdom
photo
Shane Brown
DIRECTOR BUSINESS DEVELOPMENT – WESTERN NORTH AMERICA , OLON RICERCA BIOSCIENCE LLC
Olon S.p.A
Concord, Ohio, United States
photo
Ronan Brown
SENIOR VP & HEAD, INTEGRATED GLOBAL COMPLIANCE, IQVIA, IQVIA
IQVIA
San Diego, California, United States
photo
Jason Brown, PhD
CHIEF BUSINESS OFFICER, EVEREST MEDICINES
Licensing Clinical-Stage Assets to Greater China
San Diego, California, United States
photo
Wilson Bryan, MD
DIRECTOR, OFFICE OF TISSUES AND ADVANCED THERAPIES, FDA
Race Against the Clock: Bringing New Cell and Gene Therapies to Market
White Oak, Maryland, United States
photo
Matt Bryant, PharmD
VP, GLOBAL MEDICAL AFFAIRS, EIGER BIOPHARMACEUTICALS
Developing a New Rare Disease Diagnostic: From Fueling Clinical Trials to Building a Market
Palo Alto, California, United States
photo
John Bucksath
CHIEF EXECUTIVE OFFICER AND BOARD MEMBER, KCAS, LLC
Bioscience Professional Toolkit - How to successfully transition to a post-academic career
Shawnee Mission, Kansas, United States
photo
Sanjay Budhdeo, MD
BUSINESS DEV. DIRECTOR, OWKIN
Can AI Prevent Epidemics?
photo
Hugues Bultot
CEO, EXOTHERA
Exothera
Brussels, Belgium
photo
TIMOTHY BURLAND, BSc, PhD
DIRECTOR OF BUSINESS DEVELOPMENT, SCARAB GENOMICS LLC
Scarab Genomics
Wisconsin, United States
photo
Stephen Byers
PROFESSOR OF ONCOLOGY, DIRECTOR, GUMC SHARED RESOURCES , DIVINER THERAPEUTICS LLC
Diviner Therapeutics LLC
Washington, District Of Columbia, United States
photo
Jeff Bylund, PhD
APPLICATIONS MANAGER, NIKON INSTRUMENTS
Nikon BioImaging Lab
Melville, New York, United States
photo
Cluster C.H.I.CO.
CLUSTER C.H.I.CO., CLUSTER C.H.I.CO.
Cluster C.H.I.CO.
Rome, Italy
photo
Andrew Cap, MD, PhD
DIRECTOR OF RESEARCH, US ARMY INSTITUTE OF SURGICAL RESEARCH/HEMATOLOGY-ONCOLOGY CONSULTANT TO THE US ARMY SURGEON GENERAL/ PROFESSOR OF MEDICINE, UNIFORMED SERVICES UNIVERSITY, US ARMY INSTITUTE OF SURGICAL RESEARCH
The human biologic response to vascular injury: a complex interaction among inflammation (innate and adaptive), coagulation and acuity of the injurious stimulus
photo
Arthur L. Caplan, PhD
PROFESSOR AND HEAD, DIVISION OF MEDICAL ETHICS, NYU SCHOOL OF MEDICINE
Bioethics Through the Lens of a Pandemic
New York, New York, United States
photo
EJane Caraway
DIRECTOR OF LIFE SCIENCES, GEORGIA DEPARTMENT OF ECONOMIC DEVELOPMENT
From Innovation to Impact...Georgia USA
Atlanta, Georgia, United States
photo
Anne-Marie Carbonell, MD
CEO, ONCOSYNERGY, INC
OncoSynergy, Inc
Greenwich, Connecticut, United States
photo
Justin Carbungco
ASSOCIATE DIRECTOR, SMALL SCALE MANUFACTURING, SAMSUNG BIOLOGICS
Economics of Stainless Steel and Single-Use Systems
photo
Marlene Cardin
DIRECTOR OF PROJECTS, PROSENSUS
ProSensus
Burlington, Ontario, Canada
photo
Martha Carlin
CEO/FOUNDER, THE BIOCOLLECTIVE, LLC
The BioCollective, LLC
Denver, Colorado, United States
photo
Steve Carney
MANAGING EDITOR, DRUG DISCOVERY TODAY
Finding hidden treasure - how AI/ML can harness existing data to accelerate drug discovery
Digital Biomarkers: A New Dawn in CNS R&D
Richmond, United Kingdom
photo
John Carpten, PhD
PROFESSOR, CHAIR, AND DIRECTOR, UNIVERSITY OF SOUTHERN CALIFORNIA
Can Precision Medicine Work for Everyone? Tackling the Challenge of Healthcare Disparities
Los Angeles, California, United States
photo
Alan Carr
SENIOR ANALYST, NEEDHAM & CO.
How to Fix the Broken Antibiotics Market: A Rare Disease Case Study
New York, New York, United States
photo
Dorn Carranza, MBA, PhD
DIRECTOR OF INNOVATION AND INDUSTRY PARTNERSHIPS, VENTUREWELL
Diversity and Inclusion in the Bio-innovation Ecosystem
Hadley, Massachusetts, United States
photo
Rich Carter
VICE PRESIDENT, CHIEF DIGITAL OFFICER, ELI LILLY AND COMPANY
The Emerging Role of Digital Biomarkers in Cognitive Impairment
Indianapolis, Indiana,
photo
Charlotte Casebourne
CEO, THEOLYTICS
Theolytics
Oxford, United Kingdom
photo
Alan Cash
CEO, METVITAL, INC.
MetVital, Inc.
San Diego, California, United States
photo
Grace Castillo-Soyao
FOUNDER/CHIEF INNOVATION & STRATEGY OFFICER , SELF CARE CATALYSTS
Self Care Catalysts Inc
Toronto , Ontario, Canada
photo
Susan Catalano, PhD
CO-FOUNDER AND CSO, COGNITION THERAPEUTICS
Brave Innovations: Public and Private Solutions to Advance Alzheimer’s Therapeutics and Diagnostic in a Risk-Averse Climate
Pittsburgh, Pennsylvania, United States
photo
Laura Cerni
CLUSTER MANAGER, CBM - SMART HEALTH CLUSTER OF FRIULI VENEZIA GIULIA REGION
CBM - Cluster Smart Health of Friuli Venezia Giulia, Italy
Trieste, Italy
photo
Jacob Chacko, MD
PRESIDENT, CHIEF EXECUTIVE OFFICER AND BOARD MEMBER, ORIC PHARMACEUTICALS
Looking for the Next Targeted Oncology Blockbuster
South San Francisco, California, United States
photo
Chang Hoon Chae
GENERAL MANAGER, CELLDI
CELLDI
Jeollabuck Do, Korea, Republic of
photo
Sharon Chan, MBA, MPH, D. Phil
HEAD JLABS @ SHANGHAI, JOHNSON & JOHNSON INNOVATION
How an Innovation Ecosystem Enables Growth During Times of Crisis and Beyond
China
photo
Robert Charles, JD, LLM, MPH
CHIEF, MEDICAL RESEARCH LAW, US ARMY MEDICAL RESEARCH AND DEVELOPMENT COMMAND
How to Leverage Military Non-Dilutive Funding for Your Product Development Plan
Fort Detrick, Maryland, United States
photo
Helen Chen
GREATER CHINA MANAGING PARTNER, L.E.K. CONSULTING, LLC
How will healthcare systems adapt to the Post-COVID-19 World?
Shanghai, China
photo
Anthony (Tony) Chen
PARTNER, JONES DAY
WHY PATENTS STILL MATTER: Building Your Patent Portfolio for Global Collaborations
Shanghai, China
photo
Mo Chen
CEO, WNT SCIENTIFIC
Wnt Scientific LLC
New York, New York, United States
photo
Ruoxi Chen
ASSOCIATE, WARBURG PINCUS
Investors Corner: Digital Health Funding Outlook - Raising Money During Economic Uncertainty
New York, New York, United States
photo
Andrea Chicca
CEO, CO-FOUNDER, SYNENDOS THERAPEUTICS
Synendos Therapeutics
Allschwil, Switzerland
photo
Constantine Chinoporos
CHIEF BUSINESS OFFICER, BOSTON PHARMACEUTICALS
Boston Pharmaceuticals
Cambridge, Massachusetts, United States
photo
Lorraine Chiroiu
CHIEF EXECUTIVE OFFICER, AUSBIOTECH
Australia - Global Innovation Hub
Melbourne, Australia
photo
Ho Cho, PhD
SVP, DISCOVERY BIOTHERAPEUTICS, BRISTOL MYERS SQUIBB
Bispecific Antibodies Catching Fire
San Diego, California, United States
photo
Mario Chojkier
CO-FOUNDER AND CHIEF MEDICAL OFFICER, XFIBRA, INC.
XFIBRA, Inc.
Del Mar, California, United States
photo
Michael Chui, MS, PhD
PARTNER, MCKINSEY & COMPANY
The Bio Revolution: Innovations transforming economies, societies, and our lives
San Francisco, California, United States
photo
Jon Jongsik Chun, PhD
CEO, CHUNLAB, INC.
ChunLab, Inc.
Seoul, Korea, Republic of
photo
Guy Cipriani, BS, MBA
CBO, MICROBION CORPORATION
Microbion Corporation
Bellingham, Washington, United States
photo
Ryan Cirz
CHIEF SCIENTIFIC OFFICER, ACTING CHIEF EXECUTIVE OFFICER, REVAGENIX, INC.
How to Fix the Broken Antibiotics Market: A Rare Disease Case Study
South San Francisco, California, United States
photo
Paul Cizdziel, MBA, PhD
GLOBAL MARKET DEVELOPMENT, YOKOGAWA ELECTRIC CORPORATION
Yokogawa Electric Corporation
Yokohama, Japan
photo
Laura Clague
CHIEF FINANCIAL OFFICER, RETROPHIN
Next Generation Orphan Drug Incentives
San Diego, California, United States
photo
Christopher Clegg
PRESIDENT, TRIA BIOSCIENCE
TRIA Bioscience
Seattle, Washington, United States
photo
Jeffrey Cleland
CHAIRMAN, CEO & PRESIDENT, ASHVATTHA THERAPEUTICS
Ashvattha Therapeutics
Redwood City, California, United States
photo
Dan Close, PhD
CHIEF SCIENTIFIC OFFICER, 490 BIOTECH
490 BioTech
Knoxville, Tennessee, United States
photo
Jennifer Cochran, PhD
PROFESSOR AND CHAIR, BIOENGINEERING, STANFORD UNIVERSITY
Bispecific Antibodies Catching Fire
California, United States
photo
Oren Cohen, MD
HEAD OF CPS AND CHIEF MEDICAL OFFICER, COVANCE
Covance
photo
Ezra Cohen, MD
MEDICAL ONCOLOGIST, ASSOCIATE DIRECTOR, TRANSLATIONAL SCIENCE, MOORES CANCER CENTER, UC SAN DIEGO HEALTH
What Was Hot at ASCO 2020? Highlights from the World’s Biggest Oncology Meeting
La Jolla, California, United States
photo
Ellen Coleman
PRESIDENT & CEO, VOZ ADVISORS
Patient Engagement in Gene and Cell Therapy: What is Different?
New York, New York, United States
photo
Tony Coles, MD
CHIEF EXECUTIVE OFFICER AND CHAIRPERSON OF THE BOARD OF DIRECTORS, CEREVEL THERAPEUTICS, LLC
Leading Through Crisis: Speaking Up and Out on Equity, Diversity, and Inclusion Issues Impacting our World
Boston, Massachusetts, United States
photo
Grace Colon
PRESIDENT & CEO, INCARDA THERAPEUTICS INC.
Digital Health in Respiratory Care – The Next Frontier
United States
photo
Ian Colrain
PRESIDENT - BIOSCIENCES DIVISION, SRI INTERNATIONAL
SRI International
Menlo Park , California, United States
photo
Andrea Conforto
SALES & MARKETING – BIOSERVICES DIRECTOR , OLON S.P.A
Olon S.p.A.
Milano, Italy
photo
Clive Cookson
SCIENCE EDITOR, FINANCIAL TIMES
Science on the Front Lines & on the Front Page
London, United Kingdom
photo
Pierre Courteille, MBA
CHIEF COMMERCIAL OFFICER & VICE PRESIDENT OF BUSINESS DEVELOPMENT, ABIVAX; VICE PRESIDENT, FRANCE BIOTECH, ABIVAX; FRANCE BIOTECH
Start Me Up: How Can Europe’s Biotech Sector Combat the Coronavirus?
PARIS, France
photo
Scott Cousins, MD
PROFESSOR OF OPHTHALMOLOGY AND IMMUNOLOGY, DUKE EYE CENTER
Mitochondria: How the Relic from Biology Class Could be the Next Powerhouse for Biopharmaceutical Innovation
Durham, North Carolina, United States
photo
Gabriela Couto
PRESIDENT, CR BIOMED
CR biomed
San José, Costa Rica
photo
Stan Crooke, MD, PhD
FOUNDER, CEO AND CHAIRMAN OF THE BOARD, N-LOREM FOUNDATION
n-Lorem Foundation
Carlsbad, California, United States
photo
Everett Crosland
SVP, COMMERCIAL, APPLIEDVR
Payers and Digital Therapeutics: How to Get Coverage When Doctors Prescribe Software
United States
photo
Roger Crystal
PRESIDENT AND CEO, OPIANT PHARMACEUTICALS
Opiant Pharmaceuticals
Santa Monica, California, United States
photo
Michael Curran
ASSOCIATE PROFESSOR, DEPARTMENT OF IMMUNOLOGY , MD ANDERSON CANCER CENTER
Future of IO Checkpoint Combinations
Houston, Texas, United States
photo
Wendy Cutler
VICE PRESIDENT AND MANAGING DIRECTOR, WASHINGTON, D.C. OFFICE, ASIA SOCIETY POLICY INSTITUTE
International Trade in the Times of COVID-19
photo
Corey Cutler, FRCP (C), MD, MPH
PHYSICIAN, DIRECTOR AND MEDICAL DIRECTOR OF THE ADULT STEM CELL TRANSPLANTATION AND STEM CELL TRANSPLANTATION SURVIVORSHIP PROGRAMS, DANA FARBER CANCER INSTITUTE
Transplant 2.0: Driving Forward Innovation for Patients with Blood Cancer
photo
Bassil Dahiyat
PRESIDENT AND CHIEF EXECUTIVE OFFICER, XENCOR
Bispecific Antibodies Catching Fire
Monrovia , California, United States
photo
Dave Daly
CHIEF EXECUTIVE OFFICER, THRIVE EARLIER DETECTION CORP.
How Can the Liquid Biopsy Market Realize Its $30B Potential?
Cambridge, Massachusetts, United States
photo
Corinne Danan
EVP, PARTNERSHIPS BU, HALIODX
HalioDx
Marseille, France
photo
Doug Danison, MBA
SVP, HEAD OF ACCESS VALUE & EVIDENCE STRATEGY, BLUEBIRD BIO
Financing Transformative Therapies: Cross-sector perspective on value, payment and real-world evidence
Cambridge, Massachusetts, United States
photo
Mark Dant
FOUNDER AND EXECUTIVE DIRECTOR, THE RYAN FOUNDATION; BOARD CHAIR, EVERYLIFE FOUNDATION FOR RARE DISEASES
Genomic medicine and bioethics – Ushering in a new era of responsible healthcare
Dallas, Texas, United States
photo
Barry Datlof
CHIEF, BUSINESS DEVELOPMENT AND COMMERCIALIZATION, U.S. ARMY MEDICAL RESEARCH AND DEVELOPMENT COMMAND
Many Happy Returns: Federal Labs as Commercialization Partners
Fort Detrick, MD, Maryland, United States
photo
Nathaniel David, PhD
CO-FOUNDER AND PRESIDENT, UNITY BIOTECHNOLOGY
Redefining What it Means to Get Old: New Breakthroughs in Aging Biology
photo
Hugh Davis, PhD
CHIEF OPERATING OFFICER & PRESIDENT, BIOSION USA, INC., BIOSION, INC.
Biosion, Inc.
Newark, Delaware, United States
photo
Khrystal K Davis, JD
PATIENT ADVOCATE, TEXAS RARE ALLIANCE
Get Engaged! How to Talk to ICER and Anyone Else Forming Opinions About Your Care Coverage
Austin, Texas, United States
photo
Jared Davis
VICE PRESIDENT OF TECHNICAL OPERATIONS AND MANUFACTURING, ARCTURUS THERAPEUTICS
How COVID-19 Is Reshaping Vaccine Development: Innovations in Vaccine Technology and Manufacturing Partnerships
United States
photo
Philip Davy, PhD
DIRECTOR OF BUSINESS DEVELOPMENT, BRAIZON THERAPEUTICS, INC.
Braizon Therapeutics, Inc.
Tokyo, Japan
photo
Marianne De Backer, MBA, PhD
GLOBAL HEAD OF BUSINESS DEVELOPMENT & LICENSING, EXECUTIVE COMMITTEE MEMBER, BAYER PHARMACEUTICALS
Striking the delicate balance of externalizing biopharma R&D to maximize innovation: Strategies to buy vs. build
Berkley, California, United States
photo
Isabelle de Cremoux
CEO AND MANAGING PARTNER, SEVENTURE
Keys to the Cure: Will the Microbiome Live Up to the Hype?
photo
Mark de Groot
CEO, PATTERN PHARMA INC.
Pattern Pharma Inc.
Toronto, Ontario, Canada
photo
Patrik De Haes, MD
CEO, OXURION NV
OXURION NV
LEUVEN, Belgium
photo
Alban de La Sablière
SANOFI PARTNERING HEAD, SANOFI
Sanofi
Paris, France
photo
Robert DeBerardine
CHIEF INTELLECTUAL PROPERTY COUNSEL, JOHNSON & JOHNSON
Patents in the Time of Covid-19: Innovation and Access to Medicine now and for the future
Bridgewater, New Jersey, United States
photo
Anthony DeBoer
DIRECTOR, BUSINESS DEVELOPMENT, SYNAFFIX BV
Synaffix BV
Amsterdam, Netherlands
photo
Marc Dechamps
DIRECTOR INTERNATIONAL AFFAIRS , BIOWIN
Belgium beyond biotech
Gosselies, Belgium
photo
Mark Dertzbaugh, PhD
ACTING PRINCIPAL ASSISTANT FOR RESEARCH & TECHNOLOGY , U.S. ARMY MEDICAL RESEARCH AND DEVELOPMENT COMMAND
How to Leverage Military Non-Dilutive Funding for Your Product Development Plan
Fort Detrick, Maryland, United States
photo
Raymond Deshaies
SENIOR VICE PRESIDENT, GLOBAL RESEARCH, AMGEN INC.
The Convergence of Health and Tech: Personalizing Medicine Beyond the Imaginable
United States
photo
Sriram Devanathan, BSc, MSc, PhD
SCIENTIFIC DIRECTOR, MITOCHONDRIA IN MOTION
Mitochondria in Motion, Inc
Saint Louis, Missouri, United States
photo
Ratna Devi
CHAIR, INTERNATIONAL ALLIANCE OF PATIENT ORGANIZATIONS
Global Patient Advocacy in the COVID Era: What Is the Future of Patient Advocacy around the World?
photo
Simon Dew
VP BUSINESS DEVELOPMENT , EVOX THERAPEUTICS LTD
Evox Therapeutics Ltd
Oxford, United Kingdom
photo
Nazneen Dewji
CEO, CENNA BIOSCIENCES INC.
Cenna Biosciences Inc.
La Jolla, California, United States
photo
Willem Dhooge
GENERAL MANAGER , FLANDERS.BIO
Belgium beyond biotech
photo
Philippe Diaz
CEO, DERMAXON LLC
DermaXon
Missoula, Montana, United States
photo
MG Dinesh
CHIEF SCIENTIST, AGASTIYA BIOTECH
Agastiya Biotech
Temecula, California, United States
photo
Gregory DiRusso, MD
VICE PRESIDENT, MEDICINE TEAM LEAD, HEMOPHILIA, PFIZER
Advancing Rare Disease Diagnosis and Drug Development Through Partnership
photo
Greg Divis
CEO, AVADEL PHARMACEUTICALS
Avadel Pharmaceuticals
Chesterfield, MO, Missouri, United States
photo
J. Kevin Donahue, MD
CO-FOUNDER, DIRECTOR, RITHIM BIOLOGICS®, INC.
Rithim Biologics®, Inc.
Hopkinton, Massachusetts, United States
photo
Patricia Donahue
CEO, PAD BIOPHARMA
GETTING TO YES: Negotiating IP Terms in Contracts
Sonoma, Arizona, United States
photo
Oreola Donini, PhD
CHIEF SCIENTIFIC OFFICER, SOLIGENIX, INC.
Shifting the Treatment Paradigm: New tools to tackle antimicrobial resistance
Princeton, New Jersey, United States
photo
Douglas Drake
DIRECTOR CUSTOMER SOLUTIONS, CLINERION LTD
Clinerion Ltd
Basel, Switzerland
photo
Kelly Drew
CHIEF EXECUTIVE OFFICER, BE COOL PHARMACEUTICS
Be Cool Pharmaceutics
Fairbanks, Alaska, United States
photo
Caroline M. Duffy, PhD
BIOPROCESS SCIENTIST, CYTIVA
Bioscience Professional Toolkit - How to successfully transition to a post-academic career
United States
photo
Denis DUFRANE
CEO, NOVADIP BIOSCIENCES
NOVADIP Biosciences
MONT-SAINT-GUIBERT, Belgium
photo
Rajeev Dutt
PRESIDENT, CEO, CO-FOUNDER, AI DYNAMICS
How an Innovation Ecosystem Enables Growth During Times of Crisis and Beyond
photo
Shahram Ebadollahi
GLOBAL HEAD OF DATA SCIENCE AND AI, NOVARTIS
The Convergence of Health and Tech: Personalizing Medicine Beyond the Imaginable
White Plains, New York, United States
photo
Stephen Eck
CHIEF MEDICAL OFFICER, IMMATICS BIOTECHNOLOGIES
How Can the Liquid Biopsy Market Realize Its $30B Potential?
photo
Ryan Eckmeier
JOINT PROJECT MANAGER FOR CHEMICAL, BIOLOGICAL, RADIOLOGICAL, AND NUCLEAR MEDICAL, CCDC CHEMICAL BIOLOGICAL CENTER
Back to “Normal?”: The Department of Defense’s Role in COVID-19 Screening and Diagnostics
Fort Detrick, Maryland, United States
photo
Ben Edwards
CHIEF STRATEGY OFFICER, AVANCE CLINICAL
Avance Clinical
Adelaide, Australia
photo
Mark Edwards
MANAGING DIRECTOR, BIOSCIENCE ADVISORS
Restarting the Bioeconomy: What IPO and Alliance Data tell us
Walnut Creek, California, United States
photo
Konstantinos Efthymiopoulos, MBA, PhD, PharmD
DESIGNATED MANAGING DIRECTOR, SYNDERMIX AG
SynDermix AG
Stans, Switzerland
photo
Tony Eglezos
VP BUSINESS DEVELOPMENT, STARPHARMA HOLDINGS LIMITED
Starpharma Holdings Limited
Abbotsford, Australia
photo
Joe Eiden
CHIEF CLINICAL CONSULTANT, FLUGEN INC.
The Quest for a Universal Influenza Vaccine: Within reach or beyond our grasp?
photo
Alan Eisenberg
VICE PRESIDENT, GLOBAL GOVERNMENT RELATIONS AND PUBLIC POLICY, ALNYLAM PHARMACEUTICALS, INC.
How will healthcare systems adapt to the Post-COVID-19 World?
In an Era of Partisan Stalemate, What Drug Pricing Policies Can the Executive Branch Enact Without Congressional Authority?
Cambridge, Massachusetts, United States
photo
Nathan Elia
DIRECTOR, INVESTMENT, GOVERNMENT OF VICTORIA
State Government of Victoria, Australia
photo
Natalia Elizalde
BUSINESS DEVELOPMENT DIRECTOR, VIVEBIOTECH
VIVEbiotech
San Sebastian, Spain
photo
Julie Eller
DIRECTOR, PATIENT CENTERED STRATEGIES |HELP & SUPPORT, ARTHRITIS FOUNDATION
Understanding the Voices of Patients: Unique Perspectives on Healthcare
photo
Niels Emmerich
VICE PRESIDENT, GLOBAL HEAD SEARCH AND EVALUATION, ABBVIE
AbbVie
North Chicago, Illinois, United States
photo
John Engelhardt
DIRECTOR, IMMUNO-ONCOLOGY DISCOVERY, BRISTOL MYERS SQUIBB
Future of IO Checkpoint Combinations
photo
Steven Engle
CEO, COHBAR, INC.
Redefining What it Means to Get Old: New Breakthroughs in Aging Biology
Menlo Park, California, United States
photo
Sandra Engle, PhD
DIRECTOR, TRANSLATIONAL CELL SCIENCES, STEM CELLS AND GENOMIC ENGINEERING, BIOGEN
Organs-on-a-Chip and AI: Realizing Potential Efficiencies in Drug Discovery and Development
United States
photo
Steven Engle
CEO, COHBAR, INC.
CohBar, Inc.
Menlo Park, California, United States
photo
John Erickson
CHIEF TECHNOLOGY OFFICER, NIIMBL
Discover/Develop: But How Will you Manufacture Your Therapeutic?
United States
photo
Alexandra Erwin, PhD
DIRECTOR, TALENT DEVELOPMENT & EDUCATION, BIOKANSAS
Bioscience Professional Toolkit - How to successfully transition to a post-academic career
United States
photo
Cartier Esham, PhD
EXECUTIVE VICE PRESIDENT, EMERGING COMPANIES, BIOTECHNOLOGY INNOVATION ORGANIZATION
Fireside Chat with FDA Commissioner Dr. Stephen M. Hahn
photo
David Esposito
CEO, ONL THERAPEUTICS, INC.
ONL Therapeutics, Inc.
Ann Arbor, Michigan, United States
photo
Erin Estevez
SPECIAL COUNSEL, COOLEY LLP
Federal Economic Recovery Efforts for Small Biotechnology Companies
United States
photo
Philippe Etienne
AMBASSADOR OF FRANCE TO THE UNITED STATES
France - Pushing for global cooperation and solidarity: France’s approach to addressing this crisis
photo
Anthony Evans
PRESIDENT, NATIONAL BLACK CHURCH INITIATIVE
National Black Church Initiative
Washington, District Of Columbia, United States
photo
Matthias Evers
SENIOR PARTNER, MCKINSEY GLOBAL INSTITUTE
The Bio Revolution: Innovations transforming economies, societies, and our lives
photo
Karen Fallen
HEAD OF MAMMALIAN AND MICROBIAL DEVELOPMENT AND MANUFACTURING, LONZA
Lonza Pharma & Biotech
Slough, United Kingdom
photo
Eric Fallon
GLOBAL HEAD OF MANUFACTURING SCIENCE AND TECHNOLOGY, DRUG SUBSTANCE, GENENTECH, A MEMBER OF THE ROCHE GROUP
Discover/Develop: But How Will you Manufacture Your Therapeutic?
photo
Erik Falvey
SR BUSINESS DEVELOPMENT DIRECTOR, IDDI
IDDI
Paris, France
photo
Ronald Farquhar
CEO, MORNINGSIDE BIOPHARMA ADVISORY
Morningside Biopharma Advisory (MBA)
Concord, Massachusetts, United States
photo
Anthony Fauci, MD
DIRECTOR, NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES, NATIONAL INSTITUTES OF HEALTH
A Way Forward: Winning the War on COVID through Vaccines
photo
Denise Faustman
HEAD OF IMMUNOBIOLOGY LAB, MASSACHUSETTS GENERAL HOSPITAL
Future of IO Checkpoint Combinations
Charlestown, Massachusetts, United States
photo
Phil Febbo, MD
CMO, ILLUMINA
Fireside Chat with Dr. Phil Febbo, Chief Medical Officer, Illumina
photo
Vic Fedeli
ONTARIO’S MINISTER OF ECONOMIC DEVELOPMENT, JOB CREATION AND TRADE, MINISTRY OF ECONOMIC DEVELOPMENT, JOB CREATION AND TRADE
Ontario, Canada: Imagination is in our DNA
photo
Stacy Feld
HEAD, JOHNSON & JOHNSON INNOVATION, WEST NORTH AMERICA, AUSTRALIA& NEW ZEALAND, JOHNSON & JOHNSON INNOVATION CENTER
Johnson & Johnson
United States
photo
PETER FELDMAN
CEO, ARBOR LIFE LABS
ARBOR LIFE LABS
TORONTO, Ontario, Canada
photo
Steven Ferguson, CLP, MBA
SPECIAL ADVISOR, NIH OFFICE OF TECHNOLOGY TRANSFER
Many Happy Returns: Federal Labs as Commercialization Partners
Rockville, Maryland, United States
photo
Stephanie Fertig
HHS SMALL BUSINESS PROGRAM LEAD, NATIONAL INSTITUTES OF HEALTH (NIH)
The Key Role of NIH in the Product Development Pipeline
United States
photo
Justin Field
SVP OF GOVERNMENT AFFAIRS, NVCA
Federal Economic Recovery Efforts for Small Biotechnology Companies
photo
Michael Fine
MEDICAL DIRECTOR, HEALTHNET
Activating the Value of RWD/RWE in a COVID-19 World
Huntington Beach, California, United States
photo
Wainwright Fishburn
PARTNER, COOLEY LLP
Investors Corner: Digital Health Funding Outlook - Raising Money During Economic Uncertainty
San Diego, California, United States
photo
Simone Fishburn, PhD
VICE PRESIDENT AND EDITOR IN CHIEF, BIOCENTURY
The Next Generation of Medicine: Cell Therapies, Gene Therapies and Beyond
Fireside Chat with Mathai Mammen, MD, PhD, Global Head, Research and Development, Janssen Pharmaceutical Companies of Johnson & Johnson
Redwood City, California, United States
photo
Michael Fitzhugh
NEWS EDITOR, BIOWORLD, CLARIVATE
'N of Few' - Clinical Trial Design for Small Cohorts
Berkeley, California, United States
photo
Suzanne Fitzpatrick, PhD
SENIOR ADVISOR, TOXICOLOGY , THE U.S. FOOD AND DRUG ADMINISTRATION
Organs-on-a-Chip and AI: Realizing Potential Efficiencies in Drug Discovery and Development
Derwood, Maryland, United States
photo
Kyle Flickinger
VICE PRESIDENT, BIO PHARMACEUTICAL SOLUTIONS, DEEP LENS
Deep Lens, Inc.
Chester Springs, Pennsylvania, United States
photo
Vincent Forster
CEO, VERSANTIS
Versantis
Zurich, Switzerland
photo
Pierre-Alexandre Fournier
CO-FOUNDER & CEO, HEXOSKIN
Can AI Prevent Epidemics?
Canada
photo
Nicholas Franco, BSc, MBA
EVP & CHIEF BUSINESS DEVELOPMENT OFFICER, ACTELION PHARMACEUTICALS LTD, A JANSSEN PHARMACEUTICAL COMPANY OF JOHNSON & JOHNSON
Is It Time to Reconsider M&A’s Role in Portfolio Building?
Allschwil, Switzerland
photo
John Fraser, MD, PhD
DIRECTOR, CRITICAL CARE RESEARCH GROUP, THE PRINCE CHARLES HOSPITAL AND THE UNIVERSITY OF QUEENSLAND
Can AI Prevent Epidemics?
Australia
photo
Marlin Frechette
CORPORATE COMPLIANCE & QUALITY OFFICER, FUJIFILM IRVINE SCIENTIFIC
Race Against the Clock: Bringing New Cell and Gene Therapies to Market
California, United States
photo
Mark Freedman, Bchir, BSc, MBA
CEO & DIRECTOR, SUNREGEN HEALTHCARE AG
SunRegen Healthcare AG
Allschwil, Switzerland
photo
Danielle Friend, PhD
SENIOR DIRECTOR, SCIENCE AND REGULATORY AFFAIRS, BIOTECHNOLOGY INNOVATION ORGANIZATION
Race Against the Clock: Bringing New Cell and Gene Therapies to Market
Advancing Rare Disease Diagnosis and Drug Development Through Partnership
United States
photo
Adi Frish
SENIOR VP BUSINESS DEVELOPMENT AND LICENSING, REDHILL BIOPHARMA
RedHill Biopharma
Tel Aviv, Israel
photo
Tom Frohlich
CHIEF BUSINESS OFFICER, CHINOOK THERAPEUTICS
Precision Medicine Outside Oncology: One Size Does Not Fit All
Vancouver , British Columbia, Canada
photo
Claus Crone Fuglsang
CHIEF SCIENCE OFFICER AND SENIOR VICE PRESIDENT OF RESEARCH AND TECHNOLOGY, NOVOZYMES
The Bio Revolution: Innovations transforming economies, societies, and our lives
Bagsvaerd, Denmark
photo
Toshio Fujimoto, MBA, MD
GENERAL MANAGER OF SHONAN HEALTH INNOVATION PARK, TAKEDA PHARMACEUTICAL COMPANY LTD.
How an Innovation Ecosystem Enables Growth During Times of Crisis and Beyond
Fujisawa, Japan
photo
Richard Gabriel
CEO & PRESIDENT, GLG PHARMA CORPORATION
GLG Pharma
Salem, Massachusetts, United States
photo
Stephane Gagne
PRESIDENT & CEO, OVENSA INC.
Ovensa Inc.
Aurora, Ontario, Canada
photo
Jeff Galvin
CEO, AMERICAN GENE TECHNOLOGIES
American Gene Technologies
Rockville, Maryland, United States
photo
Chris Garabedian
CHAIRMAN & CEO, XONTOGENY
Derisking Early Research and Increasing Likelihood of Clinical Success
The Business of Innovation: Evolving Models for Life Science Startups to Drive Efficiency and Maximize Value
Boston, Massachusetts, United States
photo
Steve Gardner, PhD
CEO, PRECISIONLIFE LTD
Finding hidden treasure - how AI/ML can harness existing data to accelerate drug discovery
Digital Biomarkers: A New Dawn in CNS R&D
Kidlington, United Kingdom
photo
Lou Garrison, PhD
PROFESSOR EMERITUS, THE COMPARATIVE HEALTH OUTCOMES, POLICY, AND ECONOMICS (CHOICE) INSTITUTE, DEPARTMENT OF PHARMACY, UNIVERSITY OF WASHINGTON
Closing the Gap Between Regulatory Approval and Public Pricing/Listing of Innovative BioPharmaceuticals
Mercer Island, Washington, United States
photo
Bobby Gaspar, MD, PhD
CHIEF EXECUTIVE OFFICER, ORCHARD THERAPEUTICS
Orchard Therapeutics
Gene Therapy: The Long Horizon and Broad Challenges
London, United Kingdom
photo
Lewis Geffen
CO-CHAIR, LIFE SCIENCES PRACTICE, MINTZ
Licensing Clinical-Stage Assets to Greater China
Boston, Massachusetts, United States
photo
Bruce Gellin, MD, MPH
PRESIDENT, GLOBAL IMMUNIZATION, SABIN VACCINE INSTITUTE
The Quest for a Universal Influenza Vaccine: Within reach or beyond our grasp?
Washington, United States
photo
Julie Gerberding, MD, MPH
EXECUTIVE VICE PRESIDENT & CHIEF PATIENT OFFICER, MERCK & CO, INC.
Global Patient Advocacy in the COVID Era: What Is the Future of Patient Advocacy around the World?
The Next Frontier in HIV Innovation: The Transition to No Transmission
North Wales , Pennsylvania, United States
photo
Chandrabali Ghose, PhD
FOUNDER AND CEO, BIOHARMONY THERAPEUTICS
Bioharmony Therapeutics
New York, New York, United States
photo
Anirvan Ghosh, PhD
CEO, UNITY BIOTECHNOLOGY
True North: Maintaining your vision and letting scientific innovation be your guide
California, United States
photo
Filippo Giabbani
EXECUTIVE DIRECTOR, INVEST IN TUSCANY
Invest in Tuscany
Firenze, Italy
photo
Albert Gianchetti
PRESIDENT AND CEO, XYLOCOR THERAPEUTICS, INC.
XyloCor Therapeutics, Inc.
MALVERN, Pennsylvania, United States
photo
Jessica Gibson
CEO AND CO-FOUNDER, ARIEL PRECISION MEDICINE, INC.
Ariel Precision Medicine, Inc.
Costa Mesa, California, United States
photo
John Gill
PART LEADER, SAMSUNG BIOLOGICS
Get to IND Faster: Accelerated & High Performance Cell Line Development
Incheon, Korea, Republic of
photo
Roberta Gioia
CEO, GENECHRON SRL
Genechron Srl
Rome, Italy
photo
Prashant Girbane
DIRECTOR GENERAL, MAHRATTA CHAMBER OF COMMERCE, INDUSTRIES & AGRICULTURE (MCCIA)
Pune - India's innovation Capital
photo
Brad Glasscock, PharmD
GROUP VICE PRESIDENT AND HEAD OF GLOBAL REGULATORY AFFAIRS, BIOMARIN
'N of Few' - Clinical Trial Design for Small Cohorts
photo
Amanda Glassman
EXECUTIVE VICE PRESIDENT AND SENIOR FELLOW, CENTER FOR GLOBAL DEVEOPMENT
A Way Forward: Winning the War on COVID through Vaccines
photo
John Glasspool
CEO, ANTHOS THERAPEUTICS INC
Addressing the Unmet Need in Cardiovascular Disease Development
Precision financing for Durable/curative Therapies
Cambridge MA, Massachusetts, United States
photo
Gregory Glenn, MD
PRESIDENT, RESEARCH & DEVELOPMENT , NOVAVAX, INC
A Way Forward: Winning the War on COVID through Vaccines
Gaithersburg, Maryland, United States
photo
Serghei Glinca
CEO, CRYSTALSFIRST GMBH
CrystalsFirst GmbH
Marburg, Germany
photo
Mar Gonzalez-Franco
RESEARCHER, MICROSOFT RESEARCH
The Immersive Medicine of the Future: At the convergence of smart sensors, virtual reality and artificial intelligence
Redmond, Washington, United States
photo
Greg Gorgas
PRESIDENT & CHIEF EXECUTIVE OFFICER, ARTELO BIOSCIENCES
Disruptive Thinking: What's Next for Pain
La Jolla, California, United States
photo
Phil Gotwals
GLOBAL HEAD, NIBR BD&L, NOVARTIS
Novartis
Cambridge, Massachusetts, United States
photo
Grace Graham
HEALTH POLICY DIRECTOR, SENATE COMMITTEE ON HEALTH, EDUCATION, LABOR, AND PENSIONS
Protecting Our Long-Term Commitment to Care in a Post-Pandemic World
Washington, United States
photo
Stephen Graham
CEO, PICOMOLE INC.
Picomole Inc.
Moncton, New Brunswick, Canada
photo
Barney Graham, MD, PhD
DEPUTY DIRECTOR, VRC AND CHIEF, VIRAL PATHOGENESIS LABORATORY AND TRANSLATIONAL SCIENCE CORE, NIAID, NIH
The Quest for a Universal Influenza Vaccine: Within reach or beyond our grasp?
photo
James Graham
EXECUTIVE DIRECTOR, RECCE PHARMACEUTICALS LTD
Recce Pharmaceuticals Ltd
Sydney, Australia
photo
Charley Grant, BA, CFA
COLUMNIST, WALL STREET JOURNAL
Looking for the Next Targeted Oncology Blockbuster
New York City, New York, United States
photo
Fabio Grassi
FOUNDER, MV BIOTHERAPEUTICS
MV BioTherapeutics SA
Bellinzona, Switzerland
photo
Oliver Graudejus, PhD
FOUNDER, BMSEED
BMSEED
Phoenix, Arizona, United States
photo
Larry Green
CHIEF EXECUTIVE OFFICER, ABLEXIS & ALIVAMAB DISCOVERY SERVICES
Ablexis & AlivaMab Discovery Services
San Diego, California, United States
James Greenwood
James Greenwood
FORMER PRESIDENT AND CHIEF EXECUTIVE OFFICER, BIOTECHNOLOGY INNOVATION ORGANIZATION
Biotech’s Finest Hour
Fireside Chat with Jim Greenwood and Michelle McMurry-Heath, BIO
Washington, United States
photo
Sunny Grewal
COO AND CO-FOUNDER, OMNY
Omny Health
San Francisco, California, United States
photo
Bernard Grimm
DIRECTOR GENERAL, EUROPABIO
Start Me Up: How Can Europe’s Biotech Sector Combat the Coronavirus?
Brussels, Belgium
photo
Natalie Grover
REPORTER, ENDPOINTS NEWS
Shifting the Treatment Paradigm: New tools to tackle antimicrobial resistance
London, United Kingdom
photo
Franz Grus
CEO, MAINTECT GMBH
maintect GmbH
Mainz, Germany
photo
Joseph Grzymski, PhD
CHIEF SCIENTIFIC OFFICER; DIRECTOR, RENOWN HEALTH; RENOWN INSTITUTE FOR HEALTH INNOVATION
Digitizing the Genome: Enabling New Models for Population-Scale Genomics
Reno, Nevada, United States
photo
Manisha Gulati
CHIEF OPERATING OFFICER, CLARIFY HEALTH
Clarify Health
San Francisco , California, United States
photo
Moira Gunn, BS, MS, PhD
HOST, NPR/TECH NATION; ASSOCIATE PROFESSOR, USF DIRECTOR OF BIOENTREPRENEURSHIP
Demystifying buzzwords – How AI and machine learning are being used NOW in the life sciences
Genomic medicine and bioethics – Ushering in a new era of responsible healthcare
San Francisco, California, United States
photo
David Gustafson
EMERITUS RESEARCH PROFESSOR, UNIVERSITY OF WISCONSIN−MADISON’S CENTER FOR HEALTH ENHANCEMENT SYSTEMS STUDIES
Disruptive Thinking: New Tools To Transform Addiction Treatment
photo
Byoung Gwag
CEO, GNT PHARMA
GNT Pharma
Yonginsi, Gyeonggido, Korea, Republic of
photo
Christian Haas-Kwon
LIFE SCIENCE R&D ENABLEMENT LEAD, BENCHLING
Benchling
San Francisco, California, United States
photo
Kyung soo Hahm
DIRECTOR, BIOLEADERS
BioLeaders
Yongin-si, Korea, Republic of
photo
Todd Haim, PhD
CHIEF, OFFICE OF SMALL BUSINESS RESEARCH, NIH/NIA
Brave Innovations: Public and Private Solutions to Advance Alzheimer’s Therapeutics and Diagnostic in a Risk-Averse Climate
Bethesda, Maryland, United States
photo
William Hait, MD, PhD
GLOBAL HEAD, JOHNSON & JOHNSON EXTERNAL INNOVATION, JOHNSON & JOHNSON
Nature Biotechnology and Scientific American WORLDVIEW: Whiplash! How COVID-19 Will Radically Change Biomedical R&D Across the Globe
New Brunswick, New Jersey, United States
photo
Attila Hajdu, MBA, MS
VICE PRESIDENT, BUSINESS DEVELOPMENT, TRIPLE HAIR
Triple Hair
Vancouver, British Columbia, Canada
photo
Jeff Haley
DEVELOPMENT, CELANESE
Celanese
Florence, Kentucky, United States
photo
Sonia Hall, PhD
PRESIDENT & CHIEF EXECUTIVE OFFICER, BIOKANSAS
Bioscience Professional Toolkit - How to successfully transition to a post-academic career
Shawnee, Kansas, United States
photo
Laurie Halloran
CHIEF EXECUTIVE OFFICER, HALLORAN CONSULTING GROUP
'N of Few' - Clinical Trial Design for Small Cohorts
Boston, Massachusetts, United States
photo
Reza Halse, PhD
HEAD, PACIFIC BD&L HUB AND PRESIDENT, MRL VENTURES FUND, MERCK
Merck
South San Francisco, California, United States
photo
Aldric Hama
DIRECTOR, HAMAMATSU PHARMA RESEARCH, INC.
Hamamatsu Pharma Research, Inc.
Hamamatsu, Japan
photo
Margaret Hamburg, MD
FOREIGN SECRETARY, NATIONAL ACADEMIES OF SCIENCE
A Way Forward: Winning the War on COVID through Vaccines
Protecting Our Long-Term Commitment to Care in a Post-Pandemic World
photo
Buhm Han
CTO, GENEALOGY INC.
Genealogy Inc.
Seoul, Korea, Republic of
photo
Dong Wook Han
CTO, ORGANFACTORY
OrganFactory
Cheongju, Korea, Republic of
photo
Grace Han McMahon, JD, MBA
HEAD OF TRANSACTIONS, BUSINESS DEVELOPMENT & LICENSING PACIFIC INNOVATION HUB, MERCK
GETTING IT 'JUST RIGHT': The Goldilocks Strategy for Effective and Efficient IP Due Diligence Processes
South San Francisco, California, United States
photo
Matt Handel
CEO, EXPRESSCELLS
ExpressCells
Philadelphia, Pennsylvania, United States
photo
Susie Harborth
CHIEF FINANCIAL OFFICER & ADMINISTRATIVE PARTNER, MISSION BIOCAPITAL
How an Innovation Ecosystem Enables Growth During Times of Crisis and Beyond
United States
photo
David Harel
CO-FOUNDER AND CEO, CYTOREASON
CytoReason
Tel Aviv, Israel
photo
Robert Hariri, MD, PhD
CEO, CELULARITY
Natural Killer (NK) Cells: Pushing the Next Wave of Immuno-oncology Therapies
Warren, New Jersey, United States
photo
Dan Haro
EXTERNAL ENGAGEMENT MANAGER, CORPORATE DEVELOPMENT, BIOGEN
Biogen
Cambridge, Massachusetts, United States
photo
Meghan Harpole
NURSE, COVID-19 PATIENT, NURSE
Understanding the Voices of Patients: Unique Perspectives on Healthcare
United States
photo
Christine Harrison
VICE PRESIDENT, CORPORATE AFFAIRS, ORCHARD THERAPEUTICS
Patient Engagement in Gene and Cell Therapy: What is Different?
District Of Columbia, United States
photo
Beverly Harrison
HEAD, PATIENT STRATEGIES & SOLUTIONS, JANSSEN
Activating the Value of RWD/RWE in a COVID-19 World
Titusville, New Jersey, United States
photo
Alan Hartman
PARTNER, CENTERVIEW PARTNERS
How to Get Acquired: What Companies Look for When in Acquisition Mode
photo
Paul Hastings
PRESIDENT AND CEO, NKARTA THERAPEUTICS
Understanding the Voices of Patients: Unique Perspectives on Healthcare
Diversity and Inclusion in Biotech’s Explosion: ERG and Non-Profit Perspectives
South San Francisco, California, United States
photo
Richard Hatchett
CHIEF EXECUTIVE OFFICER , CEPI
A Way Forward: Winning the War on COVID through Vaccines
London , United Kingdom
photo
Rachel Haurwitz, PhD
PRESIDENT AND CEO, CARIBOU BIOSCIENCES
True North: Maintaining your vision and letting scientific innovation be your guide
Berkeley, California, United States
photo
Lou Hawthorne
CEO, NANOTICS, LLC
NaNotics, LLC
Mill Valley, California, United States
photo
Daria Hazuda
VP, INFECTIOUS DISEASES DISCOVERY & CHIEF SCIENTIFIC OFFICER, MRL CAMBRIDGE EXPLORATORY CENTER, MERCK & CO
Shifting the Treatment Paradigm: New tools to tackle antimicrobial resistance
Cambridge, Massachusetts, United States
photo
Mary Hecht-Kissell, MBA
DIRECTOR, BUSINESS DEVELOPMENT, NORTH CAROLINA BIOTECHNOLOGY CENTER
North Carolina – a global life science leader
Research Triangle Park, North Carolina, United States
photo
Jonathan Heeney
CEO, DIOSYNVAX LTD.
The Quest for a Universal Influenza Vaccine: Within reach or beyond our grasp?
photo
Brenda Hefti, JD, PhD
SENIOR VICE PRESIDENT, INTELLECTUAL PROPERTY AND LICENSING, EXELIXIS
GETTING TO YES: Negotiating IP Terms in Contracts
Alameda, California, United States
photo
Karen Heichman, PhD
SENIOR PROGRAM OFFICER, DIAGNOSTIC DEVELOPMENT, INNOVATIVE TECHNOLOGY SOLUTIONS, GLOBAL HEALTH DIVISION, BILL & MELINDA GATES FOUNDATION
Nature Biotechnology and Scientific American WORLDVIEW: Whiplash! How COVID-19 Will Radically Change Biomedical R&D Across the Globe
photo
Mo Heidaran
VICE PRESIDENT TECHNICAL, REGULATORY AND TECHNICAL CMC CONSULTING CELL, GENE THERAPY AND TISSUE ENGINEERING, PAREXEL INTERNATIONAL
Discover/Develop: But How Will you Manufacture Your Therapeutic?
United States
photo
Abraham Heifets, PhD
CEO, CO-FOUNDER, ATOMWISE, INC.
Atomwise, Inc.
Organs-on-a-Chip and AI: Realizing Potential Efficiencies in Drug Discovery and Development
San Francisco, California, United States
photo
Per Hellsund, MBA
CEO, CYBREXA THERAPEUTICS
Getting to the Tumor: Beyond the First Generation of Tumor Targeting Technologies
Cybrexa Therapeutics
New Haven, Connecticut, United States
photo
Adam Hickey
DEPUTY ASSISTANT ATTORNEY GENERAL, NATIONAL SECURITY DIVISION, US DEPARTMENT OF JUSTICE
Examining Foreign-Source Threats to Biotechnology: A Conversation with the National Security Community
photo
James J. Hickman, PhD
CHIEF SCIENTIST , HESPEROS, INC.
Disruptive Thinking: New Tools To Transform Addiction Treatment
Hesperos, Inc
Orlando, Florida, United States
photo
Michael Higgins
MANAGING DIRECTOR, BIOPHARMACEUTICALS EQUITY RESEARCH, LADENBURG THALMANN & CO. INC.
Disruptive Thinking: What's Next for Pain
New York, New York, United States
photo
Katherine High, MD
VISITING PROFESSOR; CO-FOUNDER AND FORMER PRESIDENT AND HEAD OF R&D, ROCKEFELLER UNIVERSITY; SPARK THERAPEUTICS
Realizing the Promise of Gene Therapies for Patients Around the World: A Year of Progress
Philadelphia, Pennsylvania, United States
photo
Quita Highsmith, MBA
CHIEF DIVERSITY OFFICER, GENENTECH
Can Precision Medicine Work for Everyone? Tackling the Challenge of Healthcare Disparities
South San Francisco, California, United States
photo
Seiji Hirasaki
CEO, ORICIRO GENOMICS
OriCiro Genomics
Tokyo, Japan
photo
William Ho
CHIEF EXECUTIVE OFFICER, INCYSUS THERAPEUTICS, INC.
Incysus Therapeutics, Inc.
NEW YORK, New York, United States
photo
Helen Ho, PhD
VICE PRESIDENT, HEAD OF CORPORATE DEVELOPMENT, BLUEPRINT MEDICINES
Licensing Clinical-Stage Assets to Greater China
photo
Joshua Hoffman
CO-FOUNDER AND CEO, ZYMERGEN
The Bio Revolution: Innovations transforming economies, societies, and our lives
San Francisco, California, United States
photo
Michele Holcomb, PhD
EXECUTIVE VICE PRESIDENT, STRATEGY AND CORPORATE DEVELOPMENT, CARDINAL HEALTH
Rare Disease Therapies are No Longer Rare: Can the US Healthcare Reimbursement System Handle Chronic Treatments for Orphan Diseases
Ohio, United States
Natalie Holles
Natalie Holles
PRESIDENT AND CHIEF EXECUTIVE OFFICER, AUDENTES, AN ASTELLAS COMPANY
Realizing the Promise of Gene Therapies for Patients Around the World: A Year of Progress
photo
Andy Holt
VP BUSINESS DEVELOPMENT , ASKBIO
AskBio
RTP , North Carolina, United States
photo
Axel Hoos
SENIOR VICE PRESIDENT AND THERAPEUTIC AREA HEAD ONCOLOGY, GLAXOSMITHKLINE
Future of IO Checkpoint Combinations
Collegeville, Pennsylvania, United States
photo
W. Keith Hoots, MD
DIRECTOR, DIVISION OF BLOOD DISEASES AND RESOURCES, NATIONAL HEART, LUNG, AND BLOOD INSTITUTE- NATIONAL INSTITUTES OF HEALTH
The human biologic response to vascular injury: a complex interaction among inflammation (innate and adaptive), coagulation and acuity of the injurious stimulus
photo
Zachary Hornby
CEO, PRESIDENT AND DIRECTOR, BOUNDLESS BIO INC.
Looking for the Next Targeted Oncology Blockbuster
La Jolla, California, United States
photo
Ken Horne
PRESIDENT & COO, TEON THERAPEUTICS, INC.
Teon Therapeutics, Inc.
Redwood City, California, United States
photo
Robert House
SENIOR VICE PRESIDENT, GOVERNMENT CONTRACTS, OLOGY BIOSERVICES, INC
The Need for Speed: Developing COVID-19 Vaccines and Therapeutics
Alachua, Florida, United States
photo
Sonny Hsiao
CEO AND PRESIDENT, ACEPODIA BIOTECH, INC.
Acepodia Biotech, Inc.
Burlingame, California, United States
photo
Dar-Jen Hsieh, PhD
CEO, ACRO BIOMEDICAL CO., LTD.
ACRO Biomedical Co., Ltd.
Kaohsiung City, Taiwan
photo
Pearl Huang, PhD
PRESIDENT AND CEO, CYGNAL THERAPEUTICS
Getting a seat at the table: how can new small companies enter the oncology space?
Cambridge, Massachusetts, United States
photo
Tom Hughes, PhD
CEO, NAVITOR PHARMACEUTICALS
Redefining What it Means to Get Old: New Breakthroughs in Aging Biology
Cambridge , Massachusetts, United States
photo
Kevin Kyung-Hwa Huh
VICE CHAIRMAN, KPBMA(KOREA PHARMACEUTICAL AND BIO-PHARMA MANUFACTURERS ASSOCIATION)
KPBMA(Korea Pharmaceutical and Bio-Pharma Manufacturers Association)
Seoul, Korea, Republic of
photo
Greg Hunt, MP
MINISTER, DEPARTMENT OF HEALTH, AUSTRALIA
International Plenary Session: How are Global Leaders Collaborating to Combat the Pandemic?
photo
Stephen Hurst, JD
CO-FOUNDER, EXECUTIVE CHAIRMAN AND CO-CEO, MIND MEDICINE
Disruptive Thinking: New Tools To Transform Addiction Treatment
Toronto, Ontario, Canada
photo
Patricia Hurter
CEO, LYNDRA THERAPEUTICS
Lyndra Therapeutics
Watertown , Massachusetts, United States
photo
Mikael Hwang
BUSINESS DEVELOPMENT , GENEMEDICINE CO., LTD.
GeneMedicine Co., Ltd.
Seoul, Korea, Republic of
photo
Albert Hwang, MD
MANAGING DIRECTOR, HEALTHCARE, INVESTMENT BANKING, MORGAN STANLEY
Realizing the Promise of Gene Therapies for Patients Around the World: A Year of Progress
photo
Robert Iannone, MD
EXECUTIVE VICE PRESIDENT, RESEARCH AND DEVELOPMENT, JAZZ PHARMACEUTICALS
Advancing Rare Disease Diagnosis and Drug Development Through Partnership
photo
Jacqueline Iversen
FOUNDER AND HEAD OF CLINICAL DEVELOPMENT, SEN-JAM PHARMACEUTICAL
Sen-Jam Pharmaceutical
Huntington, New York, United States
photo
Mridula Iyer
GENERAL MANAGER, PRECISION MEDICINE, QUEST DIAGNOSTICS
Developing a New Rare Disease Diagnostic: From Fueling Clinical Trials to Building a Market
photo
Ehsan Jabbarzadeh, PhD, MBA
CEO, OBSIDIO, INC.
Obsidio, Inc.
Columbia, South Carolina, United States
photo
Mandy Jackson
MANAGING EDITOR, US COMMERCIAL NEWS, SCRIP/THE PINK SHEET
Fireside Chat with Dr. Jeff Settleman, Chief Scientific Officer for Oncology Research and Development, Pfizer
Derisking Early Research and Increasing Likelihood of Clinical Success
photo
Derek Jantz, BA, PhD
CHIEF SCIENTIFIC OFFICER, PRECISION BIOSCIENCES
CARs in the Fast Lane? Universal Allogeneic Therapy Moving Forward
Durham, North Carolina, United States
photo
Elizabeth Jeffords
CHIEF COMMERCIAL & STRATEGY OFFICER, ALKAHEST
Battle of the Brains: Rethinking Neurodegenerative Disease Treatment
San Carlos, California, United States
photo
Sarah Jenna
CEO, MY INTELLIGENT MACHINES
My Intelligent Machines (MIMs)
Montreal, Quebec, Canada
photo
Jana Jensen, PhD
CHIEF OPERATING OFFICER, DEERFIELD MANAGEMENT | DEERFIELD DISCOVERY AND DEVELOPMENT COMPANY (3DC)
Derisking Early Research and Increasing Likelihood of Clinical Success
New York, New York, United States
photo
Samuel Ji
COO / MANAGING DIRECTOR, YBSOFT CO., LTD.
YBSOFT Co., Ltd.
Goyang-si, Korea, Republic of
photo
Changrong Ji
ENTERPRISE ARCHITECT, CAREFIRST BLUECROSS BLUESHIELD
Can AI Prevent Epidemics?
photo
Li Jiang
CEO, VITASCAN
VitaScan
Ithaca, New York, United States
photo
Yefei Jin
CEO, THIRD ROOM
Third Room
Cambridge, Massachusetts, United States
photo
Sabrina Johnson
CEO, DARé BIOSCIENCE
Redefining BioPharma in a Female-Forward World
Daré Bioscience
san diego , California, United States
photo
Ramsey Johnson, MSM
FOUNDER AND CHAIRMAN, OUTBIO
Diversity and Inclusion in Biotech’s Explosion: ERG and Non-Profit Perspectives
Boston, Massachusetts, United States
photo
Patrick Jordan
CEO, MYCOVIA PHARMACEUTICALS, INC.
Redefining BioPharma in a Female-Forward World
Durham, North Carolina, United States
photo
Claude JORIS
SECREATARY GENERAL, BIOALPS
BioAlps: The Health Valley Ecosystem
Geneva, Switzerland
photo
Stephen Joseph
BUSINESS DEVELOPMENT, BREX
Brex
San Francisco, California, United States
photo
Doo Young Jung
CEO/FOUNDER, PINOTBIO, INC.
PinotBio, Inc.
Suwon, Gyeonggi-do, Korea, Republic of
photo
Ashish Kachru, MBA, MS
CHIEF EXECUTIVE OFFICER, ALTRUISTA HEALTH
Demystifying buzzwords – How AI and machine learning are being used NOW in the life sciences
Reston, Virginia, United States
photo
Dan Kagan, PhD
COO, SCIENTIST.COM
Scientist.com
Solana Beach, California, United States
photo
Kenji Kakuta
PRESIDENT AND CEO, IHEART JAPAN CORPORATION
iHeart Japan Corporation
Kyoto, Japan
photo
Rasika Kalamegham
GROUP DIRECTOR, US REGULATORY POLICY, GENENTECH
Patient-Centric 2.0: Are We Ready for Decentralized Trials?
Digital Health: Innovation Meets Regulation
Washington, United States
photo
Kevin Kane
CEO, PHASTAR
PHASTAR
London, United Kingdom
photo
Sukmo Kang, DVM, PhD
GENERAL MANAGER, BIOTOXTECH. CO. LTD
Biotoxtech
Cheongju-si, Korea, Republic of
photo
Byoung Heon Kang
CEO, SMARTINBIO
SmartinBio
Osong, Korea, Republic of
photo
Amit Kapoor
CHAIR, INSTITUTE FOR COMPETITIVENESS
The Lure of Universal Healthcare ! What India is doing in Healthcare
Gurgaon, Haryana, India
photo
Mahesh Karande
PRESIDENT & CEO, OMEGA THERAPEUTICS
Omega Therapeutics
Cambridge, Massachusetts, United States
photo
Tejal Karia
GLOBAL HEAD OF RISK MANAGEMENT, CATALENT PHARMA SOLUTIONS
Identify and Mitigate: “Bet Your Company” Risks
United States
photo
Kenneth Kashkin
CHIEF OPERATING OFFICER, CHROMOCELL CORPORATION
Chromocell Corporation
North Brunswick, New Jersey, United States
photo
David C. Kaslow, MD
VP, ESSENTIAL MEDICINES, PATH
Beyond the Needle: Novel Approaches to Vaccine Delivery
Seattle, Washington, United States
photo
David Katz, PhD
CEO/FOUNDER, SPARROW PHARMACEUTICALS
Sparrow Pharmaceuticals
Sparrow Pharmaceuticals, Inc.
Portland, Oregon, United States
photo
Syed Kazmi, PhD, MBA
PRESIDENT AND CEO, JUBILANT THERAPEUTICS INC
Jubilant Therapeutics Inc
Bedminster, New Jersey, United States
photo
Michael Keane, BS
DIRECTOR OF SEARCH AND EVALUATION AT GSK CONSUMER HEALTHCARE EXTERNAL INNOVATION, GSK CONSUMER HEALTHCARE
Demystifying buzzwords – How AI and machine learning are being used NOW in the life sciences
Warren, New Jersey, United States
photo
Ellen Kelly, PhD
DIRECTOR, BUSINESS DEVELOPMENT, CORIELL INSTITUTE FOR MEDICAL RESEARCH
Coriell Institute for Medical Research
Camden, New Jersey, United States
photo
Larry Kelmar
VICE PRESIDENT, GOVERNMENT PROGRAMS, CEPHEID
Back to “Normal?”: The Department of Defense’s Role in COVID-19 Screening and Diagnostics
Sunnyvale, California, United States
photo
Ralph Kern, MD
PRESIDENT AND CHIEF MEDICAL OFFICER, BRAINSTORM CELL THERAPEUTICS
Brainstorm Cell Therapeutics
New York , New York, United States
David Kerwick
David Kerwick
LEGAL DIRECTOR, MERCK
AI Innovations: To Patent or Not to Patent?
White Plains, New York, United States
photo
Bill Ketelbey, MBA, MD
CEO & MANAGING DIRECTOR, ACTINOGEN MEDICAL
Actinogen Medical
Sydney, Australia
photo
Rachna Khosla
VICE PRESIDENT, AMGEN INC.
Amgen Inc.
Thousand Oaks, California, United States
photo
Ute Kilger
PARTNER, BOEHMERT & BOEHMERT LAW FIRM
Patents in the Time of Covid-19: Innovation and Access to Medicine now and for the future
Berlin, Germany
photo
Nicole Kilgore
DEPUTY JOINT PRODUCT MANAGER, JOINT PROGRAM EXECUTIVE OFFICE FOR CHEMICAL, BIOLOGICAL, RADIOLOGICAL, AND NUCLEAR DEFENSE/JOINT PRO
The Need for Speed: Developing COVID-19 Vaccines and Therapeutics
Frederick, Maryland, United States
photo
Kyu-Tae Kim
CSO, ABCLON
AbClon
Seoul, Korea, Republic of
photo
Hong-Yeoul Kim
CEO, HAIM BIO CO.,LTD.
Haim Bio Co.,Ltd.
Seoul, Korea, Republic of
photo
Thomas Kim, JD, MS
PRESIDENT & CEO, EPIVARIO INC.
PTSD treatment limitations and novel pharmacotherapy approaches to transform standard of care
Lansdale, Pennsylvania, United States
photo
Wankyu Kim
CEO, KAIPHARM CO., LTD.
KaiPharm Co., Ltd.
Seoul, Korea, Republic of
photo
Julie Kim
PRESIDENT, PLASMA-DERIVED THERAPEUTICS BUSINESS UNIT, TAKEDA
Leveraging Innovative Technology to Treat COVID-19 Patients
photo
Taehee Kim
PROJECT MANAGER, INCHEON FREE ECONOMIC ZONE
Incheon Free Economic Zone (IFEZ)
photo
Andrew Kim
ASSOCIATE DIRECTOR, DSP MSAT, SAMSUNG BIOLOGICS
Samsung Biologics
Incheon, Korea, Republic of
photo
Pk Kim
DIRECTOR, NU EYNE
Nu Eyne
Seoul-si, Korea, Republic of
photo
J. Joseph Kim, PhD
PRESIDENT, CHIEF EXECUTIVE OFFICER, DIRECTOR, INOVIO PHARMACEUTICALS
Bioethics Through the Lens of a Pandemic
United States
photo
Nikole Kimes
CEO AND CO-FOUNDER, SIOLTA THERAPEUTICS
Keys to the Cure: Will the Microbiome Live Up to the Hype?
United States
photo
Nina Kjellson
MANAGING PARTNER, CANAAN PARTNERS
The Business of Innovation: Evolving Models for Life Science Startups to Drive Efficiency and Maximize Value
Menlo Park, California, United States
photo
Thomas Kluz
SENIOR INVESTMENT MANAGER, QUALCOMM VENTURES
Investors Corner: Digital Health Funding Outlook - Raising Money During Economic Uncertainty
San Diego, California, United States
photo
Jeff Kmetz
CHIEF BUSINESS OFFICER, ASCENTAGE PHARMA GROUP
Ascentage Pharma Group
Rockville, Maryland, United States
photo
Rob Knight, PhD
PROFESSOR, PEDIATRICS, BIOENGINEERING, AND COMPUTER SCIENCE & ENGINEERING, UNIVERSITY OF CALIFORNIA SAN DIEGO
Next Generation Advances in Human Microbiome Research
San Diego, California, United States
photo
Helen Knight
PROGRAMME DIRECTOR – TECHNOLOGY APPRAISAL AND HIGHLY SPECIALIZED TECHNOLOGY, NICE - NATIONAL INSTITUTE FOR HEALTH AND CARE EXCELLENCE
Closing the Gap Between Regulatory Approval and Public Pricing/Listing of Innovative BioPharmaceuticals
photo
Selina Koch, PhD
EXECUTIVE EDITOR, BIOCENTURY, INC.
Battle of the Brains: Rethinking Neurodegenerative Disease Treatment
The Business of Innovation: Evolving Models for Life Science Startups to Drive Efficiency and Maximize Value
United States
photo
Wayne Koff
PRESIDENT & CEO, HUMAN VACCINES PROJECT
The Quest for a Universal Influenza Vaccine: Within reach or beyond our grasp?
New York, New York, United States
photo
Michael Kokesh, BS, JD
PRESIDENT & CEO, VICARDIA THERAPEUTICS, INC.
ViCardia Therapeutics, Inc.
San Francisco, California, United States
photo
Daphne Koller
FOUNDER AND CEO, INSITRO, INC.
The Bio Revolution: Innovations transforming economies, societies, and our lives
South Can Francisco, California, United States
photo
Michele Korfin, MBA, RPh
CHIEF OPERATING OFFICER, TYME TECHNOLOGIES INC
TYME Technologies Inc
New York, New York, United States
photo
Jason Kralic, PhD
CEO AND CO-FOUNDER, TELLUS THERAPEUTICS
Tellus Therapeutics
Durham, North Carolina, United States
photo
Carl Kraus
CEO, ARREVUS INC.
Arrevus Inc.
Raleigh, North Carolina, United States
photo
Achim Krauss
CEO AND PRESIDENT, AXEROVISION, INC.
AxeroVision, Inc.
Carlsbad, California, United States
photo
Pawel Krysiak
PRESIDENT & CEO, M6P THERAPEUTICS
M6P Therapeutics
San Francisco, California, United States
photo
Hannah Kuchler
JOURNALIST, FINANCIAL TIMES
Redefining What it Means to Get Old: New Breakthroughs in Aging Biology
photo
Carl Kukkonen
PARTNER, JONES DAY
AI Innovations: To Patent or Not to Patent?
San Diego, California, United States
photo
Jitendra Kumar
MANAGING DIRECTOR, BANGALORE BIOINNOVATION CENTRE
Karnataka - An Emerging Bio-Innovation Hub
photo
Seema Kumar, MS
VICE PRESIDENT OF INNOVATION, GLOBAL HEALTH AND POLICY COMMUNICATION, JOHNSON & JOHNSON INNOVATION
Science on the Front Lines & on the Front Page
The BioGENEius and GenePool Challenges
How COVID-19 Has Impacted the Global Psyche
photo
Rebecca Kurnat
DIRECTOR, TECHNOLOGY SELECTION AND EVALUATION, JPEO-CBRND ENABLING BIOTECHNOLOGIES (JPEO-CBRND-EB)
The Need for Speed: Developing COVID-19 Vaccines and Therapeutics
Fort Detrick, Maryland, United States
photo
Sharon Labreche
VICE PRESIDENT, GLOBAL TALENT ACQUISITION, ALNYLAM
Diversity and Inclusion in Biotech’s Explosion: ERG and Non-Profit Perspectives
photo
Louise Lagerqvist
PARTNERING MANAGER, US, MEDINCELL
MedinCell
Jacou, France
photo
Shoupeng Lai
EVP/ CO-FOUNDER, LEADS BIOLABS
LEADS BioLabs
Nanjing, China
photo
Thomas Lake
SVP, VACCINE DEVELOPMENT ALLIANCES, VAXXAS
Beyond the Needle: Novel Approaches to Vaccine Delivery
Sydney, Australia
photo
Janet Lambert, MBA
CEO, ARM
Patient Engagement in Gene and Cell Therapy: What is Different?
Washington DC, District Of Columbia, United States
photo
Jordan Lancaster, PhD
CEO, AVERY THERAPEUTICS, INC
Avery Therapeutics, Inc
Tucson, Arizona, United States
photo
Gerardo Lancia, MBA
HEAD OF TECH TRASFER, CLUSTER & SPECIAL PROJECTS - LAZIO INNOVA SPA, LAZIO INNOVA SPA
Invest in Lazio
Rome, Italy
photo
Paul Langley
HEALTH ECONOMIST, MAIMON RESEARCH LLC
Get Engaged! How to Talk to ICER and Anyone Else Forming Opinions About Your Care Coverage
Tucson, Arizona, United States
photo
James Lanthier
CEO, MINDSET PHARMA
Mindset Pharma
Toronto, Ontario, Canada
photo
Donna LaVoie
PRESIDENT & CEO, LAVOIEHEALTHSCIENCE
The Power of Content in Your Virtual Presentation – How to Create Your Company Presentation in Just 15 Slides
Boston, Massachusetts, United States
photo
Matthew Lawrence, MD, PhD
CHIEF EXECUTIVE OFFICER & CHIEF SCIENTIFIC OFFICER, VIRSCIO
Battle of the Brains: Rethinking Neurodegenerative Disease Treatment
New Haven, Connecticut, United States
photo
David Leach
CEO, LIGNAMED, LLC
LignaMed, LLC
Philadelphia, Pennsylvania, United States
photo
Thomas Leary
PROTEIN PRODUCT SPECIALIST, DNASTAR, INC.
DNASTAR Inc.
Madison, Wisconsin, United States
photo
Seth Lederman
CHIEF EXECUTIVE OFFICER, TONIX PHARMACEUTICALS HOLDING CORP/.
Tonix Pharmaceutical Holding Corp.
New York, New York, United States
photo
Johnsee Lee, MBA, PhD
FOUNDER AND CEO, PERSONAL GENOMICS, INC.
Nature Biotechnology and Scientific American WORLDVIEW: Whiplash! How COVID-19 Will Radically Change Biomedical R&D Across the Globe
Personal Genomics, Inc.
Zhubei, Hsinchu, Taiwan
photo
Merissa Lee, BSc
BD SPECIALIST, SYNCORE BIOTECHNOLOGY
SynCore Biotechnology
Taipei, Taiwan
photo
Bora Lee
IP & BD MANAGER, BIONOXX
Bionoxx Inc.
Yangsan-si, Korea, Republic of
photo
Victor Lee
CEO, VICTOGEN
VictoGen
Thousand Oaks, California, United States
photo
Kyuho Lee
CEO, ATOMICS AI
Atomics AI
Cheongju, Korea, Republic of
photo
Yuta Lee, MBA
CEO, ACCELERATED BIOSCIENCES
Accelerated Biosciences
Carlsbad, California, United States
photo
Kevin Lee, PhD
CEO, BICYCLE THERAPEUTICS
Getting to the Tumor: Beyond the First Generation of Tumor Targeting Technologies
Lexington, Massachusetts, United States
photo
Peter Lee
CORPORATE VICE PRESIDENT, AI AND RESEARCH, MICROSOFT
The Convergence of Health and Tech: Personalizing Medicine Beyond the Imaginable
Seattle, Washington, United States
photo
Arlinda Lee, PhD
ANALYST , CANACCORD GENUITY
Bispecific Antibodies Catching Fire
New York , New York, United States
photo
Christian Leisner
CEO, CDR-LIFE
CDR-Life
Schlieren - Zurich, Switzerland
photo
Anna Lembke, MD
ASSOCIATE PROFESSOR OF PSYCHIATRY AND BEHAVIORAL SCIENCES, STANFORD UNIVERSITY MEDICAL CENTER
Disruptive Thinking: New Tools To Transform Addiction Treatment
photo
Christine Lemke, PhD
EVIDATION HEALTH, CO-FOUNDER AND PRESIDENT, EVIDATION HEALTH
The Emerging Role of Digital Biomarkers in Cognitive Impairment
San Mateo, California, United States
photo
Stephan Lensky
COO/CBO, EPIMAB BIOTHERAPEUTICS
EpimAb Biotherapeutics
NEW BRAINTREE, Massachusetts, United States
photo
Stephanie Leouzon
PARTNER AND HEAD OF TORREYA EUROPE, TORREYA
Is It Time to Reconsider M&A’s Role in Portfolio Building?
London, United Kingdom
photo
Nick Leschly
PRESIDENT & CEO, BLUEBIRD BIO
Next Generation Orphan Drug Incentives
Cambridge, Massachusetts, United States
photo
Rachael Lester
VICE PRESIDENT OF CORPORATE DEVELOPMENT, HARPOON THERAPEUTICS
Restarting the Bioeconomy: What IPO and Alliance Data tell us
United States
photo
Kirsten Leute
PARTNER, UNIVERSITY RELATIONS, OSAGE UNIVERSITY PARTNERS
Derisking Early Research and Increasing Likelihood of Clinical Success
Bala Cynwyd, Pennsylvania, United States
photo
Matthieu Leuwers
CHIEF BD OFFICER, PROVEPHARM LIFE SOLUTIONS
Provepharm Life Solutions
Marseille, France
photo
Jeremy Levin, MB BChir, D. Phil
CHAIRMAN OF THE BOARD OF DIRECTORS AND CHIEF EXECUTIVE OFFICER, OVID THERAPEUTICS INC.
Biotech’s Finest Hour
Leading Through Crisis: Speaking Up and Out on Equity, Diversity, and Inclusion Issues Impacting our World
Nature Biotechnology and Scientific American WORLDVIEW: Whiplash! How COVID-19 Will Radically Change Biomedical R&D Across the Globe
New York, New York, United States
photo
Cynthia Li
DIRECTOR, BUSINESS DEVELOPMENT, EXELIXIS
GETTING IT 'JUST RIGHT': The Goldilocks Strategy for Effective and Efficient IP Due Diligence Processes
Alameda, California, United States
photo
Mike Liccardo
VP CORP. DEV. & CFO, SHAREVAULT
ShareVault
Los Gatos, CA, California, United States
photo
Jay Lichter, PhD
MANAGING DIRECTOR, AVALON VENTURES; PRESIDENT & CEO, COI PHARMACEUTICALS, AVALON VENTURES
The Business of Innovation: Evolving Models for Life Science Startups to Drive Efficiency and Maximize Value
La Jolla, California, United States
photo
Emmanuel Ligner
PRESIDENT & CEO, CYTIVA
Cytiva
photo
Chern-Hooi Lim, PhD
CEO, NEW IRIDIUM
New Iridium
Boulder, Colorado, United States
photo
Erick Lin
MEDICAL DIRECTOR, MEDICAL AFFAIRS LEAD, BLUE CROSS BLUE SHIELD ASSOCIATION
Access to Personalized Medicine Drives Utilization of Genomic Tests and Targeted Therapies
Temple City , California, United States
photo
George Lin
EVP & CFO, HUA MEDICINE
Hua Medicine
Hong Kong, Hong Kong
photo
Klaus Lindpaintner
CSO/CMO, INTERVENN
InterVenn
South San Francisco, California, United States
photo
Evan Lippman
HEAD OF CORPORATE DEVELOPMENT AND BD FINANCE, GLOBAL BUSINESS DEVELOPMENT, TAKEDA PHARMACEUTICAL COMPANY LIMITED
Is It Time to Reconsider M&A’s Role in Portfolio Building?
Cambridge, Massachusetts, United States
photo
Donald Lo, PhD
DIRECTOR, DIVISION OF PRECLINICAL INNOVATION, THERAPEUTIC DEVELOPMENT BRANCH, NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES, NATIONAL INSTITUTES OF HEALTH
Drug repurposing for new treatments of rare diseases: the academic, biotech, and investor perspective
United States
photo
Christopher Locher
CEO, VERSATOPE THERAPEUTICS, INCORPORATED
Versatope Therapeutics, Inc.
Lowell, Massachusetts, United States
photo
Rob Long
EXECUTIVE DIRECTOR, UPLIFTING ATHLETES
Uplifting Athletes
Chester Springs, Pennsylvania, United States
photo
Katrina Loomis
EXECUTIVE DIRECTOR, HEAD OF EMERGING PORTFOLIO, EMERGING SCIENCE & INNOVATION, PFIZER
Digitizing the Genome: Enabling New Models for Population-Scale Genomics
photo
Ted Love, MD
PRESIDENT & CHIEF EXECUTIVE OFFICER, GLOBAL BLOOD THERAPEUTICS
Advancing Rare Disease Diagnosis and Drug Development Through Partnership
Leading Through Crisis: Speaking Up and Out on Equity, Diversity, and Inclusion Issues Impacting our World
Can Precision Medicine Work for Everyone? Tackling the Challenge of Healthcare Disparities
South San Francisco, California, United States
photo
Jeffrey Lu
CEO AND CO-FOUNDER, ENGINE BIOSCIENCES
Engine Biosciences
San Carlos, California, United States
photo
James Lu, MD, PhD
CO-FOUNDER & CHIEF SCIENTIFIC OFFICER, HELIX
Helix
Digitizing the Genome: Enabling New Models for Population-Scale Genomics
San Mateo, California, United States
photo
Heinz Lubenau
CHIEF EXECUTIVE OFFICER, VAXIMM AG
Vaximm AG
Basel, Switzerland
photo
Shun Luo
CEO, CHAIRMAN, JIANSHUN BIOSCIENCES
Thousand Oaks Biopharmaceuticals
Shanghai, China
photo
Tia Lyles-Williams, MSc
FOUNDER & CEO, LUCASPYE BIO
LucasPye BIO, LLC
Elizabeth, New Jersey, United States
photo
Steven Lynum
EXECUTIVE DIRECTOR (BASED IN USA), PHC CORPORATION
PHC Corporation
Livingston, New Jersey, United States
photo
Sandy Macrae, PhD
CEO, SANGAMO THERAPEUTICS
Genomic medicine and bioethics – Ushering in a new era of responsible healthcare
San Francisco, California, United States
photo
Marinna Madrid
CO-FOUNDER, CELLINO
Cellino
Cambridge, Massachusetts, United States
photo
Carmen Maher
SENIOR DIRECTOR MEDICAL REGULATORY/SENIOR REGULATORY ADVISOR, JPEO CBRND AND DEFENSE THREAT REDUCTION AGENCY / JOINT SCIENCE AND TECHNOLOGY OFFICE (DTRA / JSTO)
Back to “Normal?”: The Department of Defense’s Role in COVID-19 Screening and Diagnostics
Fort Detrick, Maryland, United States
photo
Stanley Maloy, PhD
ASSOCIATE VICE PRESIDENT FOR INNOVATION, SAN DIEGO STATE UNIVERSITY
Diversity and Inclusion in the Bio-innovation Ecosystem
San Diego, California, United States
photo
Mathai Mammen, MD, PhD
GLOBAL HEAD, RESEARCH & DEVELOPMENT, JANSSEN PHARMACEUTICAL COMPANIES OF JOHNSON & JOHNSON
Fireside Chat with Mathai Mammen, MD, PhD, Global Head, Research and Development, Janssen Pharmaceutical Companies of Johnson & Johnson
photo
Doug Manion, MD
CEO, KLEO PHARMACEUTICALS, INC.
Getting to the Tumor: Beyond the First Generation of Tumor Targeting Technologies
Natural Killer (NK) Cells: Pushing the Next Wave of Immuno-oncology Therapies
New Haven, Connecticut, United States
photo
Husseini Manji, FRCP (C), MD
GLOBAL THERAPEUTIC AREA HEAD, NEUROSCIENCE, JOHNSON & JOHNSON
How COVID-19 Has Impacted the Global Psyche
Titusville, New Jersey, United States
photo
Upendra Marathi
PRESIDENT & CEO, 7 HILLS PHARMA
7 Hills Pharma
Houston, Texas, United States
photo
Heidi Marchand, PharmD, RPh
GLOBAL HEAD, REGULATORY POLICY AND INTELLIGENCE, GILEAD SCIENCES
Race Against the Clock: Bringing New Cell and Gene Therapies to Market
United States
photo
Magdalena Marciniak
BUSINESS ALLIANCE DIRECTOR, RYVU THERAPEUTICS
Ryvu Therapeutics
photo
Jeff Margolis
CHAIRMAN, WELLTOK
Asymmetrical Challenges of Innovation
photo
Gary Margolis
CEO, NOTOGEN, INC.
Notogen, Inc.
Toronto, Ontario, Canada
photo
Brad Margus
CHIEF EXECUTIVE OFFICER, CEREVANCE
Battle of the Brains: Rethinking Neurodegenerative Disease Treatment
Boston, Massachusetts, United States
photo
John Markels, PhD
PRESIDENT, MERCK VACCINES, MERCK & CO.
A Way Forward: Winning the War on COVID through Vaccines
North Wales, Pennsylvania, United States
Peter Marks
Peter Marks, MD, PhD
DIRECTOR, CENTERS FOR BIOLOGICS EVALUATION & RESEARCH, US FOOD & DRUG ADMINISTRATION
A Way Forward: Winning the War on COVID through Vaccines
Realizing the Promise of Gene Therapies for Patients Around the World: A Year of Progress
FDA Town Hall
Silver Spring, Maryland, United States
photo
Michael Markus, PhD
CEO, HGE HEALTH
Digital Health in Respiratory Care – The Next Frontier
Philadelphia, Pennsylvania, United States
photo
Andy Marshall, PhD
CHIEF EDITOR, NATURE BIOTECHNOLOGY
Nature Biotechnology and Scientific American WORLDVIEW: Whiplash! How COVID-19 Will Radically Change Biomedical R&D Across the Globe
United States
photo
Brian Martin, BS, MS
HEAD OF AI IN R&D INFORMATION RESEARCH, SENIOR PRINCIPAL DATA SCIENTIST, ABBVIE
Demystifying buzzwords – How AI and machine learning are being used NOW in the life sciences
Lake Forest, Illinois, United States
photo
Linda Masat
V.P. BUSINESS DEVELOPMENT, TRIANNI INC.
Trianni, Inc
San Francisco, CA, California, United States
photo
Carmela Mascio
PRESIDENT & CO-FOUNDER, LIVONYX INC.
LivOnyx Inc.
Allston, Massachusetts, United States
photo
Neal Masia, PhD
CEO, HEALTH CAPITAL GROUP